Document:

Exhibit
10.1

 

EXECUTION
VERSION

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is dated as of February 23, 2021 between Lomotif Private Limited
(UEN: 201406124D), a private company limited by shares incorporated in Singapore (the “Company”), Zash Global Media and Entertainment
Corp., a Delaware Corporation (or its controlled designee the “Purchaser”), and those selling shareholders executing this
Agreement and as listed on Exhibit 1 attached hereto (the “Selling Shareholders” or “Seller”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement, each of the Selling Shareholders desires to sell and transfer to the
Purchaser such type (ordinary or preference) and number of the shares of the Company as set forth opposite such Selling Shareholder’s
name on Exhibit 1 attached hereto (“Purchased Shares”), which shares in the aggregate represent at least eighty percent (80%)
of the Fully Diluted Capitalization (as defined below) of the Company immediately following the Closing, as more fully set forth in this
Agreement, for an aggregate consideration of (i) One Hundred Million Dollars ($100,000,000.00) in cash, less (ii) the Closing Options
Payout Amount for the Terminated Options pursuant to Section 2.1(c) and Section 2.2(b), less (iii) any amount payable to the holders
of the Outstanding Convertible Notes in connection with the transactions contemplated pursuant to this Agreement and the Transaction
Documents (the “Transaction”) which have not been converted into Ordinary Shares prior to the Closing, if any.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE
I DEFINITIONS

 

Section
1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings set forth
in this Section 1.1:

 

“A&R
Constitution” means the amended and restated constitution of the Company in the form and substance reasonably satisfactory to the
Purchaser, to be adopted with effect from Closing.

 

“A&R
Shareholders Agreement” means the amended and restated shareholders agreement of the Company in the form and substance agreed between
the Company and the Purchaser, including the terms attached hereto as Exhibit 2.

 

“ACRA”
means the Accounting and Corporate Regulatory Authority of Singapore. “Affiliate” means any Person that, directly or indirectly
through one or more intermediaries, controls, is controlled by or is under common control with a Person, provided that the term “control”
(including the terms “controlling,” “controlled by” and “under common control with”) means the possession,
direct or indirect, of the majority of the voting rights or share capital of the Person or otherwise power to direct or cause the direction
of the management and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise.

 

“Aggregate
Shareholder Consideration” means the Purchase Price minus any Note Repayment Amount.

 

    	 

    	 

    

 

“Applicable
Law” means all laws, rules and regulations applicable to the Person, conduct, transaction, covenant, document or contract in question,
including all applicable common law and equitable principles, all provisions of all applicable Singapore and other relevant jurisdictions
constitutions, statutes, rules, regulations, treaties, directives and orders of any Governmental Authority, and all orders, judgments
and decrees of all courts and arbitrators.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day other than a Saturday or Sunday or public holiday on which banks in Singapore and New York City (in the State
of New York in the United States of America), are open for general banking operations.

 

“Capital
Lease” of a Person means any lease of Property by such Person as lessee which would be classified as a capital lease on a balance
sheet of such Person prepared in accordance with SFRS.

 

“Capital
Lease Obligations” of any Person means all obligations (including sales tax obligations) of such Person under Capital Leases.

 

“Closing
Payment Schedule” means a schedule prepared in accordance with terms of this Agreement and certified by the Company’s chief
financial officer or chief executive officer, that lists each of (a) the amounts payable to each of the Selling Shareholders, (b) any
Note Repayment Amounts paid or to be paid at Closing to any holders of the Outstanding Convertible Notes, (c) the Closing Options Payout
Amount payable to each holder of the Terminated Options, and (d) any amounts payable to UMG in connection with the exercise and termination
of the UMG Warrant.

 

“Company
Owned Intellectual Property” means any Intellectual Property that is or is purported to be owned by the Company or any Subsidiary.

 

“Company
Source Code” means the source code of software that comprises part of the Company Owned Intellectual Property”.

 

“Company
Systems” means the computers, servers, devices, networks, software, and systems used in connection with the operation of the Company’s
and its Subsidiaries’ business.

 

“Constitution”
means the constitution of the Company in effect as of the date hereof.

 

“Contract”
means any legally binding agreement, contract, loan, indenture, note, bond,lease,
license, binding commitment, undertaking or other legally binding agreement or obligation.

 

“Contractual
Obligations” means as to any Person, any agreement, undertaking, contract, indenture, mortgage, deed of trust or other instrument
or arrangement (whether in writing or otherwise) to which such Person is a party or by which it or any of such Person’s property
is bound.

 

“Corporate
Secretary” means Central Chambers Law Corporation.

 

“Disclosure
Schedules” means all disclosure schedules delivered pursuant to Article V of this Agreement and includes, without limitation, Schedules
1.1(a), 1.1(b), 1.1(c), 1.1(d), 2.6(a)(vii) and 8.1.

 

“Environmental
Laws” means any and all Singapore and other relevant jurisdictions statutes, laws, judicial decisions, regulations, ordinances,
rules, judgments, orders, decrees, plans, injunctions, Licenses, concessions, grants, franchises, agreements and other governmental restrictions
relating to (a) the protection of the environment, (b) the effect of
the environment on human health, (c) emissions, discharges or releases of pollutants, contaminants, hazardous substances or wastes into
surface water, ground water, air or land, or (d) the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of pollutants, contaminants, hazardous substances or wastes or the clean-up or other remediation thereof.

 

    	2

    	 

    

 

“Founding
Shareholders” means Mr. Zhiwen (defined below) and Loh Xiu Hui.

 

“Fraud”
means an act in the making of a representation or warranty contained in this Agreement, committed by a Person making such representation
or warranty, with intent to deceive another Person, and to induce such Person to enter into this Agreement and requires (a) a false representation
of material fact made herein; (b) actual knowledge that such representation is false; (c) an intention to induce the Person to whom such
representation is made to act or refrain from acting in reliance upon it; (d) causing that Person, in justifiable reliance upon such
false representation and with ignorance to the falsity of such representation, to take or refrain from taking action; and (e) causing
such Person to suffer damage by reason of such reliance.

 

“Fully
Diluted Capitalization” means the sum of: (a) the outstanding shares of Ordinary Shares; (b) the shares of Ordinary Shares directly
or indirectly issuable upon conversion or exchange of all outstanding securities directly or indirectly convertible into or exchangeable
for Ordinary Shares, including all Preference Shares, and the exercise of all outstanding options and warrants; and (c) the shares of
Ordinary Shares reserved, but neither issued nor the subject of outstanding awards under any equity incentive or similar plan of the
Company, provided that the Fully Diluted Capitalization shall exclude any shares of the Company issuable upon conversion of any Zash
Convertible Notes.

 

“Governmental
Authority” means the government of any nation, state, city, locality or other political subdivision of any thereof, any entity
exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government, regulation or compliance,
including, without limitation, any Singapore or other relevant jurisdictions public utility commission, and any corporation or other
entity owned or controlled, through stock or capital ownership or otherwise, by any of the foregoing.

 

“Indebtedness”
means, with respect to any Person, without duplication, such Person’s(a) obligations for borrowed money, (b) obligations representing
the deferred purchase price of Property or services (other than accounts payable arising in the ordinary course of such Person’s
business payable on terms customary in the trade and not outstanding more than 90 days past the date of invoice), (c) obligations, whether
or not assumed, secured by Liens or payable out of the proceeds or production from Property now or hereafter owned or acquired by such
Person, (d) obligations which are evidenced by bonds, debentures, notes, acceptances, or other similar instruments, (e) obligations of
such Person to purchase securities or other Property arising out of or in connection with the sale of the same or substantially similar
securities or Property, (f) Capital Lease Obligations and obligations created or arising under any conditional sale or other title retention
agreement, (g) Off-Balance Sheet Liabilities, (h) attributable indebtedness related to Sale and Leaseback Transactions, (i) the aggregate
undrawn face amount of all letters of credit issued for the account and/or upon the application of such Person together with all unreimbursed
drawings with respect thereto, (j) any obligation to repurchase or redeem
Shares of such Person other than at the sole option of such Person, (k) any obligation guaranteeing or intended to guarantee (whether
directly or indirectly guaranteed, endorsed, co-made, discounted, or sold with recourse) any obligation of any other Person that constitutes
Indebtedness under any of clauses (a) through (k), and (l) any other obligation for borrowed money or other financial accommodation which,
in accordance with SFRS, would be shown as a liability on the balance sheet of such Person.

 

    	3

    	 

    

 

“Intellectual
Property” means all of the following in any jurisdiction throughout the world: (a)
trademarks, service marks, trade dress, brand names, corporate names, trade names, fictitious names, logos, slogans, and other indicia
of origin (whether registered or unregistered, and all translations, adaptations, derivations and combinations of, and applications for,
the foregoing and all registrations and renewals thereof) and any goodwill related to the foregoing (collectively, “Trademarks”);
(b) all Internet domain names, URLs, social media accounts and handles, and all applications, registrations and renewals in connection
therewith; (c) all inventions (whether patentable or unpatentable and whether or not reduced to practice) and all improvements thereto;
(d) all patents, patent applications and patent invention disclosures together with all reissuances, continuations, continuations-in-part,
divisions, revisions, extensions and re-examinations thereof; (e) all works of authorship, software, and other copyrightable works, all
registered and unregistered copyrights in both published and unpublished works, moral rights of authors, and all other rights of authorship
recognized by statute or otherwise and all applications, registrations and renewals in connection therewith; (f) all trade secrets and
proprietary and confidential information, know-how, processes, customer lists, financial information and formulae; and (g) the right
to sue and recover for past, present or future infringements, misappropriations or other conflict with any intellectual property.

 

“IP
Rights” shall have the meaning as set forth in this Agreement.

 

“Knowledge
of the Company”, or any similar phrases, means the actual and, after due inquiry, constructive knowledge of any director or executive
officer of the Company.

 

“Licenses”
means all licenses, permits, authorizations, determinations, and registrations issued by any Governmental Authority to the Company in
connection with the conduct of its business.

 

“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Long
Stop Date” means that date that is sixty (60) days from the signing date of this Agreement, provided, however, that (a) if on or
prior to such date, the Company shall have failed to deliver to Purchaser the deliverables set forth in Sections 2.6(a) and (e) below
and/or the Selling Shareholders shall have failed to deliver to Purchaser the deliverables set forth in Section 2.6(b) below (in each
case other than deliverables that can only be delivered against payment of the Purchase Price if the Purchase Price is not available
to be paid at Closing), unless any of the foregoing deliverables is expressly waived in writing by Purchaser in its sole discretion,
then the Long Stop Date shall be automatically extended by thirty (30) days, making the Long Stop Date ninety (90) days from the signing
date of this Agreement (the “Initial Long Stop Date Extension”), provided, further that it will be a condition precedent
to the Initial Long Stop Date Extension that the Purchaser pay prior to the date that is sixty (60) days from the signing date of this
Agreement to the Company by wire transfer of immediately available funds in cash an additional amount equal to One Million Dollars ($1,000,000)
(the “Extension Payment”) pursuant to a Convertible Note Subscription Agreement in the form attached hereto as Exhibit 4
to be executed and delivered by the Company to the Purchaser concurrently with the payment of such additional amount; and (b) following
the Initial Long Stop Date Extension, if on or prior to the date ninety (90) days from the signing date of this Agreement, the Purchaser
has provided evidence of available funds in an amount equal to the Purchase Price in a form reasonably satisfactory to the Company (which
may include a letter of credit, binding commitment of funding from a third party or acquiror of Purchaser, evidence of funds held in
an account controlled by Purchaser or funds that are subject to a written agreement to be released upon the Closing, or the like) to
consummate the Closing and the Company shall have failed to deliver to Purchaser the deliverables set forth in Sections 2.6(a) and (e)
below and/or the Selling Shareholders shall have failed to deliver to Purchaser the deliverables set forth in Section 2.6(b) below, unless
any of the foregoing deliverables is expressly waived in writing by Purchaser in its sole discretion, then the Long Stop Date shall be
extended by an additional thirty (30) days, making the Long Stop Date one hundred twenty (120) days from the signing date of this Agreement.

 

    	4

    	 

    

 

“Losses”
means actual out-of-pocket losses, damages, liabilities, deficiencies, actions, judgments, interest, awards, penalties, fines, liabilities
and costs and expenses of every kind and nature actually incurred by the applicable party and agreed to by the parties or awarded by
a court of competent jurisdiction in a final non-appealable order (including reasonable attorneys’ fees, expert consultant and
witness fees, and costs of investigation and enforcing any right to indemnification hereunder and the cost of pursuing any insurance
providers); provided that “Losses” shall not include consequential damages, punitive damages, indirect damages, diminution
of value or exemplary damages unless and only to the extent actually awarded to a third party in a third party claim; provided, further,
for purposes of computing the amount of Losses incurred or paid by a Person, there shall be deducted an amount equal to the amount of
any insurance proceeds, indemnification payments, contribution payments or reimbursements that are actually received by such Person or
any of such Person’s Affiliates in connection with such Losses (net of any deductibles, self-insured retentions, Taxes or expenses
incurred in connection with such recovery).

 

“Material
Adverse Effect” shall mean a material adverse condition, event, occurrence or development related to, or material adverse change
or effect on (a) the Transaction, (b) the business, assets, results of operations, cash flows, condition (financial or otherwise), or
prospects of the Company and its Subsidiaries taken as a whole, (c) the legality, validity, binding effect or enforceability against
the Company of this Agreement, provided, however, that none of the following shall be deemed in themselves, either alone or in combination,
to constitute, and none of the following shall be taken into account in determining whether there has been or will be, a Material Adverse
Effect: (i) any changes resulting from general market, economic, financial, capital markets or political or regulatory conditions, (ii)
any changes or proposed changes of Applicable Law or SFRS (or, in each case, authoritative interpretations thereof), (iii) any changes
resulting from weather, force majeure, epidemic, an act of terrorism, war, national or international calamity, or any worsening thereof,
(iv) any changes generally affecting the industries in which the Company and its Subsidiaries conduct their businesses, (v) any changes
resulting from the execution of this Agreement or the announcement or the pendency of the Transaction, including any loss of employees
or customers, any cancellation of or delay in customer orders or any disruption in or termination of (or loss of or other negative effect
or change with respect to) customer, supplier, distributor or similar business relationships or partnerships resulting from the Transaction,
or (vi) any changes or effects resulting from any action required to be taken by the terms of this Agreement; provided, that in the case
of clauses (i), (ii), (iii) and (iv), if and only to the extent such
changes do not have a disproportionate impact on the Company and its Subsidiaries, taken as a whole, as compared to other participants
in the industries in which the Company and its Subsidiaries conduct their businesses.

 

“Material
Contract” means (a) this Agreement, (b) the agreements reflected on Schedule 1.1(a), (c) Agreements not made in the ordinary course
of business, or (d) any contract, agreement, instrument, permit, lease or license of the Company or any Subsidiary that is material to
the Company’s business or involving a commitment to pay an amount, by the Company in excess of One Hundred Thousand Dollars ($100,000)
in any twelve-month period following the Closing Date (whether or not in the ordinary course of business) or where Company actually paid
in excess of One Hundred Thousand Dollars ($100,000) during the twelve month period preceding the Closing Date; (e) any contract or agreement
for a partnership or a joint venture or for the acquisition, sale or lease of any assets or Shares of the Company or any other Person
or involving a sharing of profits; (f) any contract or agreement that is a loan agreement, credit agreement, promissory note, guarantee,
subordination agreement, letter of credit; (g) any contract or agreement that is a material binding commitment or agreement to enter
into any of the foregoing types of agreements; (h) any contracts or agreements that grant any options, grants, or rights to any individual
or entity to acquire Shares in the Company issued by the Company, or (i) any contract or agreement that limits or excludes its right
to do business and/or compete in any geographical area or field or with any person.

 

    	5

    	 

    

 

“Note
Repayment Amount” means the aggregate amount payable to the holders of any Outstanding Convertible Notes which have not been converted
into Ordinary Shares prior to the Closing, if any.

 

“Off-Balance
Sheet Liabilities” of a Person means (a) any repurchase obligation or liability of such Person with respect to accounts or notes
receivable sold by such Person, (b) any liability under any Sale and Leaseback Transaction which is not a Capital Lease, (c) any liability
under any so-called “synthetic lease” transaction entered into by such Person, or (d) any obligation arising with respect
to any other transaction which is the functional equivalent of or takes the place of borrowing but which does not constitute a liability
on the balance sheets of such Person.

 

“Ordinary
Shares” means the ordinary shares in the capital of the Company. “Outstanding

 

Convertible
Notes” means the convertible notes issued by the Company to each holder of the convertible notes set forth in Schedule 1.1(b).

 

“Per
Share Purchase Price” means the price obtained by dividing (a) the Aggregate Shareholder Consideration by (b) the total number
of Shareholder Share Equivalents.

 

“Permitted
Liens” shall mean the following:

 

(a)
Liens for Taxes, assessments or governmental charges or levies on its Property if the same shall not at the time be delinquent or thereafter
can be paid without penalty, or are being contested in good faith and by appropriate proceedings and for which adequate reserves in accordance
with SFRS shall have been set aside on its books, so long as the Company’s or its Subsidiaries’ title to, and its right to
use, its Properties are not materially adversely affected thereby;

 

(b)
Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ liens and other similar Liens arising in the
ordinary course of business which secure payment of obligations not more than 30 days past due or which are being contested in good faith
by appropriate proceedings and for which adequate reserves in accordance with SFRS shall have been set aside on its books, so long as
the Company’s or its Subsidiaries’ title to, and its right to use, its Properties are not materially adversely affected thereby;

 

(c)
(i) Utility easements, building restrictions and such other encumbrances or charges against real property as are of a nature generally
existing with respect to properties of a similar character, as arise in the ordinary course of business and that do not secure any monetary
obligations and do not materially detract from the value of the affected property or interfere with the ordinary course of business of
the Company or its Subsidiaries and (ii) minor defects in title, in each case, which do not materially interfere with the conduct of
the Company’s or its Subsidiaries’ business or the utilization thereof in the business of the Company or its Subsidiaries;
and

 

(d)
Liens existing on the date hereof and described in Schedule 1.1(c).

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

    	6

    	 

    

 

“Personal
Data” means all data or information, in the Company or its Subsidiaries’ possession or control, relating to one or more individual(s)
that is personally identifying or that is defined as “personal data”, “personal information”, “personally
identifiable information” or similar term under Applicable Laws.

 

“Preference
Shares” means, collectively, any Series Seed preference shares and Series A preference shares in the capital of the Company, with
the respective rights, preferences and privileges set out in the Constitution.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

“Property”
of a Person means any and all property, whether real, personal, tangible, intangible, or mixed, of such Person, or other assets owned,
leased, or operated by such Person.

 

“Purchase
Price” means One Hundred Million Dollars ($100,000.000.00).

 

“Purchaser
Indemnified Parties” means Purchaser and its respective Affiliates, successors and assigns (other than the Company and its Affiliates).

 

“Requirements
of Law” means as to any Person, provisions of the organizational documents of such Person, or any law, treaty, code, rule, regulation,
right, privilege, qualification, license or franchise, or any determination of an arbitrator or a court or other Governmental Authority,
in each case applicable to such Person or any of such Person’s property or to which such Person or any of such Person’s property
is subject or pertaining to any or all of the transaction.

 

“Sale
and Leaseback Transaction” means any sale or other transfer of Property by any Person with the intent to lease such Property as
lessee.

 

“Sanctioned
Entity” means (a) an agency of the government of, (b) an organization directly or indirectly controlled by, or (c) a person resident
in a country that is subject to a sanctions program identified on the list maintained by the Office of Foreign Assets Control (“OFAC”)
and available at http://www.treas.gov/offices/enforcement/ofac/programs, or as otherwise published from time to time as such program
may be applicable to such agency, organization or person.

 

“Sanctioned
Person” means a person named on the list of Specially Designated Nationals or Blocked Persons maintained by OFAC available at http://www.treas.gov/offices/enforcement/ofac/sdn/index.html,
or as otherwise published from time to time.

 

“Senior
Management” means with respect to the Company, the persons listed on Schedule 5.16.

 

“SFRS”
means Singapore financial reporting standards in effect from time to time, consistently applied. If there are any changes to SFRS during
the term of this Agreement, the parties shall continue to determine compliance with the financial covenants, and make all other financial
determinations hereunder, without giving effect to any such changes until such time that the parties hereto can agree to amend the financial
covenants and other provisions requiring financial determinations hereunder to take into account the effect of such changes to SFRS in
a mutually acceptable manner.

 

    	7

    	 

    

 

“Shareholder
Share Equivalents” means the shares or share equivalents equal to the Purchased Shares plus the number of Terminated Options
(if not already included in the Purchased Share) plus the number of Shares issued or issuable pursuant to any warrants issued
by the Company (including the UMG Warrant) or Outstanding Convertible Notes in each case that are being converted and/or exercised (for
cash or on a net-exercise) in connection with the Closing (if not already included in the Purchased Shares).

 

“Shareholders
Agreement” means the shareholders agreement of the Company, dated November 27, 2018, by and among the Company and the other parties
listed thereto, as amended from time to time.

 

“Shares”
means the Ordinary Shares and Preference Shares of the Company.

 

“Solvent”
means, with respect to any Person that (a) the fair value of the assets and the property of such Person exceeds the fair value of the
aggregate liabilities (including contingent and unliquidated liabilities) of such Person, and (b) after giving effect to the Transaction,
including payment of the Interim Payments by the Purchaser to the Company, such Person is able to both service and pay its liabilities
as they mature. In computing the amount of contingent or unliquidated liabilities at any time, such liabilities will be computed as the
amount that, in light of all the facts and circumstances existing at such time, represents the amount that is likely to become an actual
or matured liability.

 

“Subsidiary”
means with respect to the Company, Lomotif, Inc. (“Lomotif USA”) and any direct or indirect corporation, limited or general
partnership, limited liability company, trust, estate, association, joint venture or other business entity of which (a) more than 50%
of (i) the outstanding Shares have (in the absence of contingencies) ordinary voting power to elect a majority of the board of directors
or other managing body of such Company, (ii) in the case of a partnership or limited liability company, the interest in the capital or
profits of such partnership or limited liability company or (iii) in the case of a trust, estate, association, joint venture or other
entity, the beneficial interest in such trust, estate, association or other entity business is, at the time of determination, owned or
controlled directly or indirectly through one or more intermediaries, by such Company, or (b) is under the actual control of the Company.
Representations, undertakings and obligations set forth in this Agreement shall be applicable only to Subsidiaries which exist or have
existed at the applicable and relevant time.

 

“Tax”
means any present or future United States, Singapore or relevant jurisdictions income, gross receipts, license, payroll, employment,
excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, , franchise profits, withholding, social
security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative
or add-on-minimum, estimated, or other taxes, levies, assessments, fees or other charges imposed by any Governmental Authority, including
any interest, penalty, or addition thereto, whether disputed or not.

 

“Tax
Return” means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including
any schedule or attachment thereto, and including any amendment thereof.

 

“Terminated
Options” means up to 212,818 options of the Company issued and outstanding (or deemed issued and outstanding) immediately prior
to Closing, of which allocation details are set forth under the column “Terminated Options” in Schedule 1.1(d).

 

    	8

    	 

    

 

“Transaction
Documents” means this Agreement, and all exhibits and schedules hereto, including the Disclosure Schedules, and any other documents
or agreements executed in connection with the Transaction, including, without limitation, the A&R Shareholders Agreement and any
convertible notes issued or issuable to the Purchaser by the Company in connection with the Transaction.

 

“UMG
Warrant” means that certain warrant to purchase 50,787 Ordinary Shares pursuant to the terms thereof, issued by the Company to
Universal International Music B.V., dated June 5, 2019.

 

“Zash
Convertible Notes” means any convertible promissory notes issued by the Company to Zash in connection with the Initial Payments.

 

ARTICLE
II

PURCHASE
AND SALE BY THE SELLING SHAREHOLDERS

 

Section
2.1 Purchase and Sale of the Purchased Shares.

 

(a)
Subject to the terms and conditions herein set forth, the Selling Shareholders will sell to the Purchaser on the Closing Date, and the
Purchaser will acquire from each Selling Shareholder the Purchased Shares, and, in consideration for such Purchased Shares, the Purchaser
shall pay to such Selling Shareholder for each such share the Per Share Purchase Price. Exhibit 1 attached hereto sets forth the anticipated
payments to each Selling Shareholder in consideration for such Selling Shareholder’s Shares, assuming the conversion of all Outstanding
Convertible Notes, the payment of the Closing Options Payout Amount, and the net-exercise of the UMG Warrant. Notwithstanding anything
to the contrary herein, in the case of the undersigned holders of the Outstanding Convertible Notes, by executing this Agreement and
thereby accepting the terms of this Agreement, including, without limitation, Section 6.5, such holders will be deemed Selling Shareholders
and their Conversion Shares (as defined in Section 2.2(c)) will be deemed the Purchased Shares.

 

(b)
At the Closing, each Selling Shareholder shall deliver to the Purchaser the Purchased Shares as set forth on Exhibit 1 free and clear
of all Liens, restrictions and rights of others but subject to the applicable securities laws and limitations under the organizational
documents of the Company then in effect and together with all rights of any nature attached or accruing to them on or after Closing (including
the right to receive all dividends and distributions declared, paid or made by the Company on or after the Closing Date).

 

(c)
Contingent on and effective immediately prior to Closing, each Terminated Option, whether or not vested or exercisable, shall become
fully vested and exercisable immediately prior to Closing and to the extent not exercised prior to the Closing, shall be cancelled at
Closing (or, in the case of a Terminated Option which has not been granted and that is deemed issued and outstanding immediately prior
to Closing, such Terminated Option shall be cancelled at Closing without any actual issuance of such Terminated Option and the holder
thereof shall have no claim for the issuance of such Terminated Option) and, in consideration of such cancellation, the holder thereof
shall be entitled to receive, without interest, a cash payment in an amount equal to: (i) the aggregate number of the Ordinary Shares
issuable upon the exercise of such Terminated Option, multiplied by (ii) the amount by which the Per Share Purchase Price exceeds the
exercise price per share (if there is an exercise price per share) of such Terminated Option, rounding such amount down to the nearest
whole dollar (the “Closing Options Payout Amount”), subject to the terms and conditions set forth in this Agreement and the
agreements contemplated by this Agreement, including, without limitation, the release set forth in Section 9.4. The Company agrees that
the Board of Directors of the Company shall adopt such resolutions and take all other actions (including obtaining any required consents)
prior to the Closing as are required to effect the transactions described in this Section 2.1(c). All cash amounts payable in respect
of the Terminated Options held by current employees of the Company in accordance with this Section 2.1(c) shall be paid pursuant to the
Company’s standard payroll procedures, within one payroll period following the Closing Date, provided that the Company shall be
entitled to deduct any amount required to be withheld or deducted under Applicable Laws, including pursuant to Section 2.7.

 

    	9

    	 

    

 

Section
2.2 Closing Payment.

 

(a)
At the Closing, the Purchaser shall pay the applicable portion of the Purchase Price by wire transfer of immediately available funds
to each Selling Shareholder in an amount equal to the amount set forth for such Selling Shareholder in the Closing Payment Schedule.

 

(b)
At the Closing, the Purchaser shall pay to the Company the Closing Options Payout Amount by wire transfer of immediately available funds
to the account which is designated by the Company in writing at least three Business Days prior to the Closing as set forth on the Closing
Payment Schedule. Promptly after receipt of the Closing Options Payout Amount, but subject to Section 9.5, the Company will pay all cash
amounts payable to a holder of Terminated Options who is not an employee of the Company in accordance with Section 2.1(c), provided that
the Company shall be entitled to deduct any amount required to be withheld or deducted under Applicable Laws, including pursuant to Section
2.7. Payment to a holder of Terminated Options who is an employee of the Company shall be made in accordance with Section 2.1(c) and
subject to Section 9.5.

 

(c)
At the Closing and conditioned upon the delivery of executed payoff letters for each noteholder receiving any portion of the Note Repayment
Amount from the Company to the Purchaser, the Purchaser shall also pay, by wire transfer of immediately available funds, to the Company
or the Sellers’ Representative or another designee of the Company designated in writing to the Purchaser at least three (3) Business
Days before the Closing, for disbursement to each holder of the Outstanding Convertible Notes, to the extent any such Outstanding Convertible
Note has not been converted into Ordinary Shares prior to the Closing, if any, the applicable portion of the Note Repayment Amount for
such Outstanding Convertible Note, as set forth on the Closing Payment Schedule. At the Closing and conditioned upon the conversion of
an Outstanding Convertible Note listed on Schedule 1.1(b) into the number of the Ordinary Shares issued upon conversion of such notes
as set forth in Schedule 1.1(b) (the “Conversion Shares”), the Purchaser shall pay, by wire transfer of immediately available
funds, to the holder of such Outstanding Convertible Note, the amount equal to the number of Conversion Shares multiplied by the same
Per Share Purchase Price for each Purchased Share, in full consideration for the sale of all such Conversion Shares to the Purchaser.

 

Section
2.3 Signing Payment and Additional Interim Payment. Upon execution of this Agreement, the Purchaser shall pay to the Company by
wire transfer of immediately available funds in cash an amount equal to One Million Five Hundred Thousand Dollars ($1,500,000) (the “Signing
Payment”) pursuant to a Convertible Note Subscription Agreement in the form attached hereto as Exhibit 4 to be executed and delivered
by the Company to the Purchaser concurrently with the payment of the Signing Payment. The Signing Payment is non-refundable and paid
to the Company separate from the Purchase Price. This Agreement shall not become effective until the Signing Payment is received by the
Company. On or prior to the date thirty (30) days after the date hereof, the Purchaser shall pay to the Company by wire transfer of immediately
available funds in cash an amount equal to One Million Dollars ($1,000,000) (the “Additional Interim Payment”) pursuant to
a Convertible Note Subscription Agreement in the form attached hereto as Exhibit 4 (and substantially identical to the Convertible Note
Subscription Agreement for the Signing Payment) to be executed and delivered by the Company to the Purchaser concurrently with the payment
of the Signing Payment. The Additional Interim Payment is non-refundable and paid to the Company separate from the Purchase Price. If
the Additional Interim Payment is not received by the Company within thirty (30) days from the date of this Agreement, then the Company
shall have the right to terminate this Agreement in its sole discretion by providing written notice to the Purchaser. The Signing Payment
and Additional Interim Payment may be used by the Company (i) for the Company’s or its Subsidiaries’ operating expenses in
the ordinary course consistent with its past practice and in the reasonable discretion of its Chief Executive Officer, (ii) as set forth
in Exhibit 4 hereto, or (iii) otherwise upon prior written approval of the Purchaser. Notwithstanding the foregoing termination and for
the avoidance of doubt, the Convertible Note Subscription Agreement entered into between the Company and the Purchaser with respect to
the Signing Payment and the Additional Interim Payment shall remain in full force and effect.

 

    	10

    	 

    

 

Section
2.4 Additional Payment. In the event this Agreement is terminated pursuant to Section 11.1(b), the Purchaser shall pay an additional
Five Million Dollars ($5,000,000) by wire transfer of immediately available funds in cash to the Company (the “Additional Payment”
and together with the Extension Payment, Signing Payment and Additional Interim Payment, the “Initial Payments”) pursuant
to a Convertible Note Subscription Agreement in the form attached hereto as Exhibit 4 (and substantially identical to the Convertible
Note Subscription Agreement for the Signing Payment and Additional Interim Payment) to be executed and delivered by the Company to the
Purchaser concurrently with the payment of the Additional Payment. Notwithstanding the foregoing termination and for the avoidance of
doubt, the Convertible Note Subscription Agreements entered into between the Company and the Purchaser with respect to all of the Initial
Payments shall remain in full force and effect.

 

Section
2.5 Closing. The purchase and sale of the Purchased Shares shall take place at 10:00 a.m. in Singapore (the “Closing”)
on a date that is the second Business Day following the satisfaction or waiver of the conditions to closing set forth in Section 3.1
(the “Closing Date”), provided, however, the Closing shall take place on or prior to the Long Stop Date. At the Closing,
the Selling Shareholders shall deliver the Purchased Shares to the Purchaser against delivery by the Purchaser of the full purchase price
for the Purchased Shares, which is payable by wire transfer of immediately available funds.Closing Deliverables.

 

(a)
At the Closing, against performance of the obligations by the Selling Shareholders and the Purchaser set out in Section 2.6(b) and (c)
below, the Company shall:

 

(i)
authorize (x) entry onto the electronic register of members of the Company of the name of the Purchaser as the registered holder of the
Purchased Shares with effect from Closing, (y) entry onto the electronic register of directors of the Company reflecting the appointment
of the Purchaser Directors (defined below) as directors of the Company with effect from the Closing;

 

(ii)
deliver to the Purchaser, (x) the original executed Form E4A and Working Sheet D or E (as applicable) with respect to the Purchased Shares
sold by such Seller; and (y) a copy of a certificate of good standing of (aa) the Company from ACRA and (ab) Lomotif USA from the Secretary
of State of Delaware;

 

(iii)
deliver to the Purchaser and the Selling Shareholders, a certificate from a director of the Company, dated as of the Closing Date, attesting
to (A) the organizational documents of the Company as in effect on the Closing Date, and (B) the resolutions of the Company’s board
of directors and shareholders authorizing the execution, delivery and performance of the Transaction Documents and the Transaction;

 

(iv)
deliver to the Purchaser the fully executed amendment to the Audio Clips Distribution Agreement between the Company and Universal International
Music B.V. (“UMG”) dated as of June 19, 2019 (the “UMG Agreement”) extending (without any other modification
thereof) the term of the UMG Agreement through and until December 31, 2021, or as otherwise approved by the Purchaser pursuant to Section
8.1, and waiving any change-of-control rights UMG may have pursuant to the UMG Agreement in connection with this Agreement and the Transaction
Documents;

 

    	11

    	 

    

 

(v)
deliver to the Purchaser, evidence of payment in full of all amounts owing by the Company to UMG pursuant to the Judgment by Confession
in the form reviewed by the Purchaser;

 

(vi)
deliver to the Purchaser, a copy of the A&R Shareholders Agreement duly executed by all of the parties thereto (assuming delivery
by the Purchaser and each Selling Shareholder (to the extent it is a party thereto) of their respective signature pages thereto), which
will incorporate the terms set forth in Exhibit 2 (unless otherwise agreed by the parties thereto);

 

(vii)
deliver to the Purchaser, the consents set forth on Schedule 2.6(a)(vii); and

 

(viii)
deliver to the Purchaser, audited financial statements of the Company for the fiscal years 2019 and 2020, certified by independent public
accountants of nationally recognized standing reasonably acceptable to the Purchaser.

 

(b)
At or prior to the Closing, against performance of the obligations by the Company and the Purchaser set out in Section 2.6(a) and (c)
below, each Selling Shareholder shall deliver:

 

(i)
to the Corporate Secretary, the original share certificates corresponding to the Purchased Shares that such Selling Shareholder is selling,
for cancellation of the said certificates at the Closing;

 

(ii)
to the Corporate Secretary, the original share transfer forms duly executed by such Selling Shareholder with respect to the Purchased
Shares sold by such Selling Shareholder at the Closing, in form and substance satisfactory to the Purchaser and the Corporate Secretary;

 

(iii)
to the Company, a certified true copy of the member resolutions and other approvals and waivers as may be requested by the Company to
approve the execution, delivery and performance of the Transaction Documents and the Transaction;

 

(iv)
to the Company, a copy of the A&R Shareholders Agreement duly executed by such Selling Shareholder (to the extent it is a party thereto),
which will incorporate the terms set forth in Exhibit 2 (unless otherwise agreed by the parties thereto);

 

(v)
in the case of CCV Fund I LP, a letter of resignation duly executed by Wei Zhou from the board of directors of the Company, subject to
the occurrence of and with effect from the Closing;

 

(vi)
in the case of K9 Industries Pte. Ltd., to the extent a director designated by such Person was appointed to the board of directors of
the Company prior to Closing, a letter of resignation duly executed by such director from the board, subject to the occurrence of and
with effect from the Closing; and

 

(vii)
evidence that the Preference Shares held by such Selling Shareholder will be converted into Ordinary Shares immediately prior to but
in connection with the Closing.

 

    	12

    	 

    

 

(c)
At or prior to the Closing, against performance of the obligations by the Company and the Selling Shareholders set out in Section 2.6(a)
and (b) above, the Purchaser shall deliver:

 

(i)
to each Selling Shareholder, the applicable portion of the Purchase Price, by wire transfer of immediately available funds in accordance
with Section 12.10;

 

(ii)
to the Company, for disbursement in accordance with Section 2.2(b), the Closing Options Payout Amount and any Note Repayment Amount for
disbursement in accordance with Section 2.2(c);

 

(iii)
to the Corporate Secretary, (x) the share transfer forms duly executed by the Purchaser in form and substance satisfactory to the Corporate
Secretary, (y) the stamp duty amount, by wire transfer of immediately available funds, required to be paid to the Inland Revenue Authority
of Singapore in connection with the sale and purchase of the Purchased Shares, to the account designated by the Corporate Secretary in
writing at least two Business Days prior to Closing, and (z) know-your-customer information of the Purchaser and other documents reasonably
requested by the Corporate Secretary for purposes of the lodgment with ACRA of an update to the electronic register of members of the
Company;

 

(iv)
to the Corporate Secretary, a copy of the Form 45 duly executed by each of the three persons designated by the Purchaser to be a director
of the Company (each, a “Purchaser Director”), know-your-customer information of such Purchaser Directors and other documents
reasonably requested by the Corporate Secretary for purposes of the lodgment with ACRA of an update to the electronic register of directors
of the Company; and

 

(v)
to the Company, a copy of the A&R Shareholders Agreement duly executed by the Purchaser, which will incorporate the terms set forth
in Exhibit 2 (unless otherwise agreed by the parties thereto).

 

(d)
Within one (1) Business Day after the Closing, the Company shall deliver to the

Purchaser:

 

(i)
a copy of the updated electronic register of members of the Company, reflecting the name of the Purchaser as the registered holder of
the Purchased Shares with effect from Closing;

 

(ii)
a copy of the updated electronic register of directors of the Company, reflecting the appointment of the Purchaser Directors as directors
of the Company; and

 

(iii)
the original share certificates issued to the Purchaser as the holder of the

Purchased
Shares.

 

(e)
No later than three (3) Business Days prior to the Closing, the Company shall deliver to the Purchaser the final Closing Payment Schedule.

 

Section
2.7 Tax Matters.

 

(a)
The Purchaser shall be entitled to deduct and withhold from any payments made in connection with the sale of the Shares as contemplated
by this Agreement such amounts as are required to be deducted and withheld by the Purchaser under any Requirements of Law and/or Applicable
Laws (and solely to the extent of such Requirement of Law and/or Applicable Laws) with respect to the making of such payment. To the
extent that pursuant to any Requirement of Law and/or Applicable Law the Purchaser is required to furnish any information with respect
to any particular Selling Shareholder in order to minimize or eliminate any withholding obligation associated with such Selling Shareholder,
then Purchaser shall request such information from such Selling Shareholder and, provided that such Selling Shareholder has timely and
completely provided the information requested by Purchaser, Purchaser shall submit such information to the applicable Governmental Authority.
To the extent that amounts are so withheld, such amounts shall be treated for all purposes of this Agreement as having been paid to the
Selling Shareholders or such other Person in respect of whom such withholding was made.

 

    	13

    	 

    

 

(b)
Any payments made in respect of the Terminated Options pursuant to this Agreement (i) shall be treated as compensation paid by the Company
as and when received by the holder thereof to whom such payment is due, (ii) shall be net of any Taxes withheld pursuant to Section 2.7(a),
and (iii) shall, in respect of the Terminated Options that are held by employees of the Company, be made through the Company’s
standard payroll procedures in accordance with Section 2.1(c) and Section 2.2(b). Purchaser shall have no obligation with respect to
any payments required to be made to the holders of the Terminated Options or any tax withholding or related obligations applicable thereto
other than to fulfill its obligation to pay the Closing Options Payout Amount to the Company or its designee in accordance with Sections
2.1(c) and 2.2(b).

 

ARTICLE
III

CONDITIONS
TO THE OBLIGATIONS OF THE PURCHASER

 

Section
3.1 Conditions Precedent to Closing. The obligation of the Purchaser to purchase the Purchased Shares, to pay the Purchase Price
and to perform any obligations hereunder shall be subject to the satisfaction as determined by, or waived in writing by, the Purchaser
of the following conditions on or before the Closing Date; provided that any waiver of a condition shall not be deemed a waiver
of any breach of any representation, warranty, agreement, term or covenant, as specifically set forth elsewhere in this Agreement, or
of any misrepresentation by the Company or Selling Shareholders:

 

(a)
Representations and Warranties. The representations and warranties contained in Article V and Article Article VI hereof shall
be true and correct in all material respects at and as of the Closing Date (except to the extent such representations and warranties
specifically relate to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date)
after giving effect to the Transaction.

 

(b)
Compliance with the Transaction Documents. The Company shall have performed and complied in all material respects with all of
its agreements and conditions set forth or contemplated in the Transaction Documents that are required to be performed or complied with
on or before the Closing Date.

 

(c)
Certificates. The Purchaser shall have received a certificate from the Company, dated the Closing Date and signed by its chief
executive officer, certifying that (i) the attached copies of the Constitution, and resolutions of the board of directors or similar
governing body approving the Transaction Documents are all true, complete and correct and remain unamended and in full force and effect,
and (ii) the list of directors, officers and shareholders as set out in a business profile of the Company obtained on or about the Closing
Date, the information listed in Schedule 5.1 is true, complete, and correct.

 

(d)
Ownership. The Purchaser shall acquire in the aggregate no less than eighty percent (80%) of the Fully Diluted Capitalization
of the Company immediately following the Closing, without giving effect to any Zash Convertible Notes.

 

    	14

    	 

    

 

(e)
Purchase of the Purchased Shares Permitted by Applicable Laws. The acquisition of and payment for the Purchased Shares to be acquired
by the Purchaser hereunder (i) shall not be prohibited by any Requirements of Law, and (ii) shall not subject the Purchaser to any penalty
or other onerous condition under or pursuant to any Requirements of Law.

 

(f)
Consents and Approval. All consents, exemptions, authorizations, or other actions by, or notices to, or filings with, Governmental
Authorities and other Persons in respect of all Requirements of Law and with respect to those Contractual Obligations of the Sellers
and the Company necessary in connection with the execution, delivery or performance by the Sellers and the Company respectively (including,
without limitation the conversion of all Preference Shares to Ordinary Shares and the termination of the Shareholders Agreement), or
enforcement against the Sellers and the Company respectively, of the Transaction Documents shall have been made or obtained and be in
full force and effect, and, to the extent applicable, the Purchaser shall have been furnished with appropriate evidence thereof.

 

(g)
No Material Judgment or Order. There shall not be on the Closing Date any judgment, injunction or order of a court of competent
jurisdiction or any ruling of any Governmental Authority which, in the judgment of the Purchaser, would prohibit the purchase of the
Purchased Shares hereunder or subject the Purchaser to any penalty or other onerous condition under or pursuant to any Requirement of
Law if the Purchased Shares were to be purchased hereunder.

 

(h)
No Litigation. No arbitration, action, claim, suit, litigation or Proceeding before any court or any Governmental Authority shall
have been commenced or threatened against the Company (including its directors or officers) or any of its Subsidiaries, and no investigation
by any Governmental Authority shall have been commenced and no action, suit or Proceeding by any Governmental Authority shall have been
threatened in writing against the Purchaser, the Company or any Subsidiary in each case (i) seeking to restrain, prevent or change the
Transaction or questioning the validity or legality of the Transaction, or (ii) which could reasonably be expected to have a Material
Adverse Effect.

 

(i)
Good Standing Certificates. The Company shall have delivered to the Purchaser as of a date not more than ten (10) Business Days
before the Closing Date good standing certificates for the Company and its Subsidiaries for their jurisdictions of incorporation and
certificates of foreign qualification for all other jurisdictions where their ownership, lease or operation of property or the conduct
of their business requires such foreign qualification, except where the failure to be so qualified could not reasonably be expected to
have, either individually or in the aggregate, a Material Adverse Effect.

 

(j)
Senior Management. The Company’s employment agreement with each member of Senior Management shall be in full force and effect
at Closing, and the Company has received no notice or indication of any member of Senior Management’s intention to resign or terminate
their employment with the Company.

 

(k)
Zhiwen Employment Agreement. Mr. Zhiwen’s employment agreement shall be duly executed and delivered by and between the Company
and Mr. Zhiwen on terms mutually acceptable to Mr. Zhiwen and the Purchaser.

 

(l)
Accelerated Vesting. The Closing shall not trigger the payment of any material change of control payments to employees or consultants
under any agreements to which the Company is bound or the acceleration of any equity awards which would result in Purchaser purchasing
any less than eighty percent (80)% of the Fully Diluted Capitalization of the Company, without giving effect to any Zash Convertible
Note.

 

    	15

    	 

    

 

(m)
Conversion of Notes. The Company shall use its commercially reasonable efforts to ensure the Outstanding Convertible Notes shall
be fully converted to Ordinary Shares in an amount equal to the Conversion Shares. Any such Outstanding Convertible Note which has not
been converted into Ordinary Shares in an amount equal to the Conversion Shares shall be repaid at Closing through the Note Repayment
Amount. Each holder of such Outstanding Convertible Note converting into Conversion Shares hereunder shall execute this Agreement or
a written joinder agreement agreeing to become a party to this Agreement and bound by all of the terms hereof.

 

(n)
Establishment of Employee Share Options Scheme. The Company shall have delivered to the Purchaser evidence of establishment of
an employee share option scheme for the allotment and issuance of up to 427,229 Ordinary Shares in the Company.

 

(o)
Data Protection Policies. The Company shall have adopted data protection policies in a form reasonably satisfactory to the Purchaser.

 

(p) Audited
Financials. The Company shall have delivered to Purchaser the deliverable set forth in Section 2.6(a)(viii).

 

ARTICLE
IV

CONDITIONS
TO THE OBLIGATIONS OF THE COMPANY AND SELLING SHAREHOLDERS

 

Section
4.1 The obligations of the Company and Selling Shareholders to sell, or cause to be sold, the Purchased Shares and to perform its other
obligations hereunder shall be subject to the satisfaction as determined by, or waived by, the Company and Selling Shareholders of the
following conditions on or before the Closing Date:

 

(a)
Representations and Warranties. The representations and warranties of the Purchaser contained in Article VII hereof shall be true
and correct in all material respects at and as of the Closing Date as if made at and as of such date (except to the extent such representations
and warranties specifically relate to an earlier date, in which case they shall be true and correct in all material respects as of such
earlier date).

 

(b)
Compliance with Transaction Documents. The Purchaser shall have performed and complied in all material respects with all of the
agreements and conditions set forth or contemplated herein that are required to be performed or complied with by them on or before the
Closing Date.

 

(c)
Consents and Approval. All consents, exemptions, authorizations, or other actions by, or notices to, or filings with, Governmental
Authorities and other Persons in respect of all Requirements of Law and with respect to those Contractual Obligations of the Purchaser
necessary in connection with the execution, delivery or performance by the Purchaser, or enforcement against the Purchaser, of the Transaction
Documents shall have been made or obtained and be in full force and effect.

 

(d)
No Material Judgment or Order. There shall not be on the Closing Date any judgment, injunction or order of a court of competent
jurisdiction or any ruling of any Governmental Authority which would prohibit the purchase of the Purchased Shares hereunder or subject
the Company to any penalty or other onerous condition under or pursuant to any Requirement of Law if the Purchased Shares were to be
purchased hereunder.

 

    	16

    	 

    

 

(e)
No Litigation. No arbitration, action, claim, suit, litigation or Proceeding before any court or any Governmental Authority shall
have been commenced or threatened against the Company (including its directors or officers) or any of its Subsidiaries, and no investigation
by any Governmental Authority shall have been commenced and no action, suit or Proceeding by any Governmental Authority shall have been
threatened in writing against the Purchaser, the Company or any Subsidiary (i) seeking to restrain, prevent or change the Transaction
or questioning the validity or legality of the Transaction, or (ii) which could reasonably be expected to have a Material Adverse Effect.

 

(f)
Zhiwen Employment Agreement. Mr. Zhiwen’s employment agreement shall be duly executed and delivered by and between the Company
and Mr. Zhiwen on terms mutually acceptable to Mr. Zhiwen and the Purchaser.

 

ARTICLE
V

REPRESENTATIONS
AND WARRANTIES REGARDING THE COMPANY

 

Except
as set forth in any the section of the Disclosure Schedules matching the relevant section of this Article V, the Company makes the following
representations and warranties to the Purchaser as of the date hereof and as of the Closing Date:

 

Section
5.1 Existence and Power. The Company and each Subsidiary: (a) is duly organized, validly existing and in good standing under the
laws of the jurisdiction of its incorporation or formation, (b) has all
requisite corporate or limited liability company power and authority to own and operate its property, to lease the property it operates
as lessee and to conduct the business in which it is currently engaged; (c) is duly qualified as a legal entity, licensed and in good
standing under the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of its business requires
such qualification, except where the failure to be so qualified could not reasonably be expected to have, either individually or in the
aggregate, a Material Adverse Effect, and (d) has the corporate or limited liability company power and authority to execute, deliver
and perform its obligations under the Transaction Documents to which it is or will be a party at Closing. The information relating to
the Company (including, its registered office address, incorporation date, registration number and shareholding information); and jurisdictions
in which the Company and each of its Subsidiaries is organized and qualified to do business as of the Closing Date are listed on Schedule
5.1.

 

Section
5.2 Authorization; No Contravention. The execution, delivery and performance by the Company: (a) has been duly authorized by all
necessary corporate action; (b) do not and will not contravene or violate the terms of the Constitution of the Company or any of the
charter documents of its Subsidiaries or any amendment thereto or any Requirement of Law or Applicable Law applicable to the Company
or such Subsidiary or the Company’s or such Subsidiary’s assets, business or properties; (c) do not and will not (i) conflict
with, contravene, result in any violation or breach of or default under any Material Contract) with or without the giving of notice or
the lapse of time or both) other than any right to consent, which consents have been obtained, (ii) create in any other Person a right
or claim of termination or amendment of any Material Contract, or (iii) require modification, acceleration or cancellation of any Material
Contract, in each case of clauses (i) to (iii), other than such conflicts, claims or modifications, etc., which would not result in a
Material Adverse Effect; and (d) do not and will not result in the creation of any Lien (or obligation to create a Lien) against any
property, asset or business of the Company or such Subsidiary, other than such Lien which would not result in a Material Adverse Effect.

 

Section
5.3 Governmental Authorization; Third Party Consents. Except as set forth on Schedule 5.3 or the consents required under Section
2.6(a)(vii), no approval, consent, compliance, exemption, authorization, or other action by, or notice to, or filing with, any Governmental
Authority or any other Person in respect of any Requirement of Law or Material Contract, and no lapse of a waiting period under a Requirement
of Law or Material Contract, is necessary or required in connection with the execution, delivery or performance by, or enforcement against,
the Company in respect of the Transaction Documents.

 

    	17

    	 

    

 

Section
5.4 Binding Effect. The Company has duly executed and delivered this Agreement and constitutes the legal, valid and binding obligations
of the Company enforceable against the Company in accordance with their respective terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies.

 

Section
5.5 No Legal Bar. Neither the Company nor any Subsidiary has previously entered into any agreement which is currently in effect
or to which the Company or any of its Subsidiaries is currently bound granting any rights to any Person which conflict with the rights
to be granted by the Company in the Transaction Documents, other than the right to consent, which consents have been obtained.

 

Section
5.6 Litigation. Except as set forth on Schedule 5.6, (a) there are no legal actions, suits, Proceedings, prosecutions, claims
or disputes or other forms of alternative dispute resolutions pending or, to the Knowledge of the Company, threatened, at law, in equity,
in arbitration or before any Governmental Authority against or affecting the Company or its Subsidiaries seeking to restrain, prevent
or change the Transactions or questioning the validity or legality of the Transaction Documents or that could reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect; (b) there is no injunction, writ, temporary restraining order,
decree or any order or determination of any nature by any arbitrator, court or other Governmental Authority purporting to enjoin or restrain
the execution, delivery or performance of the Transaction Documents or which relates to the assets or the business of the Company or
its Subsidiaries; and (c) there is no litigation, claim, audit, dispute, inquiry, review, Proceeding or investigation currently pending
or threatened against the Company or its Subsidiaries for any violation or alleged violation of any Requirements of Law, which would
reasonably be expected to have a Material Adverse Effect, and neither and the Company nor any Subsidiaries has received written notice
of any threat of any such litigation, claim, audit, dispute, inquiry, review, Proceeding or investigation.

 

Section
5.7 Compliance with Laws. The Company and its Subsidiaries are in compliance, in all material respects, with all material Requirements
of Law. Except as set forth on Schedule 5.7, there are no actual or pending appeals, adjustments, audits, inquiries, investigations,
Proceedings, recoupments or notices of intent to audit or investigate by any Governmental Authority against the Company.

 

Section
5.8 Title to Properties. Except as set forth on Schedule 5.8, the Company and its Subsidiaries have good title to, or a valid
leasehold interest in, all Property used by such entity in its business and none of such Property is subject to any Lien, except for
Permitted Liens. The Properties owned or leased by the Company and its Subsidiaries comprise all the Properties necessary for the continuation
of the Company and its Subsidiaries’ business as currently carried on. Neither the Company nor any of its Subsidiaries depend in
any material respect on the use of Properties owned, or facilities or services provided by any Selling Shareholder.

 

Section
5.9 Real Property. Neither Company nor any Subsidiary owns any Real Property. All leases of Real Property to which Company or
any Subsidiary are included in the listing of Material Contracts. Save as including in the listing of Material Contracts, neither the
Company nor any Subsidiary has any right of ownership, right of use, option, right of first refusal, contractual obligation to purchase
or any other right affecting any land or buildings. In relation to each of the leases of Real Property as included in the listing of
Material Contracts, to the Knowledge of the Company (i) each lease is valid and in full force and effect; (ii) the rents and other monies
due and payable under the lease have been paid in full and on time; (iii) the Company and each Subsidiary (as applicable) has performed
its respective obligations and observed its respective covenants under the lease; (iv) there is no right for the landlord to terminate
the lease or take possession of the relevant part of the Property before the expiry of the contractual term (other than as a result of
a breach of its terms by the Company and each Subsidiary (as applicable); (v) there is no provision requiring the Company (or the Subsidiary,
as applicable) to reinstate the relevant part of the Real Property on expiry of the lease; and (vi) there are no rent reviews pending
or in progress.

 

    	18

    	 

    

 

Section
5.10 Taxes.

 

(a)
Except as set forth on Schedule 5.10, the Company and each of its Subsidiaries has timely filed all Singaporean, United States and other
relevant jurisdictions income and other material Tax Returns that it was required to file, in each case with due regard for any extension
of time within which to file such Tax Return and no such Tax Returns are subject of any dispute with any competent Governmental Authority.
All such Tax Returns were correct, accurate and complete in all material respects. All Taxes due and payable by the Company or its Subsidiaries
have been paid, in each case with due regard for any extension of time within which to file such Tax Return, other than any Taxes the
amount or validity of which is being actively contested by Company or its Subsidiaries in good faith and by appropriate proceedings and
with respect to which adequate reserves or other appropriate provision, if any, as shall be required in conformity with Company’s
accounting practices shall have been made or provided therefor. There are no Liens, other than Permitted Liens, on any of the assets
of the Company or its Subsidiaries that arose in connection with any failure (or alleged failure) to pay any Tax. No claim has been made
by a Governmental Authority in a jurisdiction where the Company and its Subsidiaries do not file Tax Returns that the Company or any
of its Subsidiaries is or may be subject to taxation by that jurisdiction.

 

(b)
Except as set forth on Schedule 5.10, there is no action, suit, Proceeding, investigation, examination, audit, non-routine visit or claim
now pending or threatened in writing by any Governmental Authority regarding any Taxes relating to the Company or its Subsidiaries. Neither
the Company nor any of its Subsidiaries has entered into an agreement, concession or waiver or been requested to enter into an agreement
or waiver extending any statute of limitations relating to the payment or collection of Taxes of such Person and there are no circumstances
that would cause the taxable years of the Company or its Subsidiaries not to be subject to the normally applicable statute of limitations.

 

(c)
Except as set forth on Schedule 5.10, the Company and each of its Subsidiaries, in all material respects, have (i) collected all sales,
use, value added and other taxes required to be collected, and have remitted such amounts to the appropriate Governmental Authority or,
if applicable, have furnished properly completed exemption certificates for all exempt transactions; and (ii) properly made all deductions
and withholdings on account of Tax required to be made in respect of any payment made or benefit provided before the date of this agreement
and has to the extent required by Requirements of Law or Applicable Law in its respective jurisdiction of incorporation properly accounted
for all such deductions and withholdings.

 

(d)
The Company and each of its Subsidiaries, have maintained and have in their possession or under their control all records and documentation
that are required to be maintained for the purposes of any Tax and to calculate respective Company or Subsidiary’s obligations
in respect of Tax.

 

(e)
Neither the Company nor any of its Subsidiaries has had its tax affairs dealt with on a consolidated basis or formed a fiscal unity nor
have any of them entered into any tax allocation or sharing arrangement (including any arrangement under which tax losses or tax reliefs
are surrendered or claimed or agreed to be surrendered or claimed) in respect of its profits, gains or losses or those of another company.

 

    	19

    	 

    

 

(f)
Neither the Company nor any of its Subsidiaries has claimed or been granted exemption from Tax or the benefit of any other special Tax
regime in connection with reorganizations, demergers or mergers.

 

Section
5.11 Financial Condition. The Company has furnished the Purchaser with true, correct and complete copies of (collectively, the
“Financial Statements”): the unaudited balance sheet of the Company as of December 31, 2020 and the statement of income for
the fiscal year ended December 31, 2020. Such Financial Statements: truly and fairly present, in all material respects, the financial
position of the Company and its Subsidiaries, as of the respective dates thereof, and the results of operations thereof, as of the respective
dates or for the respective periods set forth therein, and are in conformity with SFRS, Requirements of Law, Applicable Law and the past
historical practices of the Company. Except as set forth on Schedule 5.11, as of the dates of the Financial Statements, neither the Company
nor any Subsidiary had any obligation, Indebtedness or liability (whether accrued, absolute, contingent or otherwise, and whether due
or to become due), which was not reflected or reserved against in the balance sheets which are part of the Financial Statements, except
for those incurred in the ordinary course of business and which are fully reflected on the books of account of the Company or its Subsidiaries.

 

(b)
All accounting and financial records of the Company and its Subsidiaries have been properly kept and maintained in accordance with Requirements
of Law and Applicable Law, are up to date, constitute an accurate record in all material respects, of all matters which ought to appear
in them and are in their possession or under their control.

 

Section
5.12 Absence of Certain Changes or Events. Since December 31, 2020, there has been no development, event, circumstance, or change
which would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect.

 

Section
5.13 Environmental Matters. The Company and its Subsidiaries have materially complied with all applicable Environmental Laws,
rules and regulations. Neither the Company nor any of its Subsidiaries has ever been cited for any violation of any Environmental Laws
by any Governmental Authority. There has been no unlawful leakage or spillage by the Company of hazardous wastes or hazardous pollutants
onto or beneath the surface of the premises where the Company’s or its Subsidiaries’ businesses are being conducted, so as
to cause the same to be contaminated.

 

Section
5.14 Subsidiaries. Except as set forth on Schedule 5.14, the Company does not (a) have any Subsidiaries, or (b) own of record
or beneficially, directly or indirectly, any (y) Shares issued by any other Person or (z) equity, voting or participating interest in
any joint venture or other enterprise. Neither the Company nor its Subsidiaries: (i) has agreed to acquire, any shares, securities or
other interests in, any company; (ii) is or has agreed to become a member of any partnership or other unincorporated association, joint
venture or consortium (other than recognized trade associations); or (iii) is a party to any profit-sharing arrangement.

 

    	20

    	 

    

 

Section
5.15 Capitalization. As of the Closing Date, after giving effect to the Transaction, the capitalization of the Company and its
Subsidiaries shall be as set forth on Schedule 5.15 and the Purchaser shall own no less than eighty percent (80%) of the Fully Diluted
Capitalization of the Company, without giving effect to any Zash Convertible Notes. All of the issued and outstanding Shares of the Company
has been, and Shares of the Company issuable upon the exercise of outstanding securities when issued will be, duly authorized and validly
issued and are fully paid and nonassessable. Except as set forth on Schedule 5.15, the issuance of the foregoing Shares has not been
subject to preemptive rights in favor of any Person other than such rights that have been waived or complied with and will not result
in the issuance of any additional Shares of the Company or the triggering of any anti-dilution or similar rights contained in any options
warrants, debentures or other securities or agreements of the Company or any of its Subsidiaries. On the Closing Date, assuming the Closing
shall have occurred, except as set forth on Schedule 5.15, there are no outstanding securities convertible into or exchangeable for Shares
of the Company or any of its Subsidiaries or options, warrants or other rights to purchase or subscribe for Shares of the Company or
any of its Subsidiaries, or contracts, commitments, agreements, understandings or arrangements of any kind to which the Company or any
of its Subsidiaries is a party relating to the issuance of any Shares of the Company or any of its Subsidiaries, or any such convertible
or exchangeable securities or any such options, warrants or rights. On the Closing Date, except as set forth on Schedule 5.15 and Schedule
1.1(d), neither the Company nor any of its Subsidiaries has any obligation, whether mandatory or at the option of any other Person, at
any time to issue, transfer, redeem or repurchase any Shares of the Company or any of its Subsidiaries, pursuant to the terms of its
Constitution or otherwise. The Company further warrants that the list of issued options that are issued or deemed issued as at Closing
as listed in Schedule 5.15 and Schedule 1.1(d) is true and correct. On the Closing Date, except as set forth on Schedule 5.15, neither
the Company nor any of its Subsidiaries maintains nor has any obligation under any share option plan or other equity compensation related
plans or agreements. Except as set forth on Schedule 5.15, the Shareholders Agreement or the Constitution, no issued and outstanding
shares of the Company’s Shares are subject to a right of first refusal or condition of forfeiture in favor of the Company, and
no shares of the Shares of the Company are subject to vesting restrictions. Except as set forth on Schedule 5.15, since December 31,
2020, the Company has not declared or paid, or become responsible to declare or pay, and the Company is not responsible for or have any
obligation to declare or pay, a dividend or other distribution on its securities or otherwise combined, split, recapitalized or taken
similar actions with respect to its outstanding Shares. Except as set forth on Schedule 5.15, the Shareholders Agreement or the Constitution,
there are no voting trusts, proxies or other contracts or understandings to which the Company is a party or is bound with respect to
the voting of any shares of the Company’s Shares, the acquisition (including rights of co-sale, first refusal, antidilution or
pre-emptive rights), disposition, registration of securities of the Company, or other rights of securityholders, or obligations of the
Company, with respect to the securities of the Company. All securities of the Company and its Subsidiaries have been and were issued,
allotted and, to the Knowledge of the Company, transferred in compliance, in all material respects, with all securities and other Applicable
Laws and the Constitution, and in compliance with all requirements of applicable contracts affecting, applicable to or relating to, such
issuances and transfers, and in relation to Purchased Shares, be free from any Liens.

 

Section
5.16 Labor Relations.

 

(a)
Schedule 5.16 sets forth a list of the Senior Management of the Company and the employment agreements for each such individual. Other
than as set forth on Schedule 5.16, the Company has not entered into any other contracts or agreements, especially with respect to compensation
or benefits, with Senior Management. None of the Senior Management is obligated under any contract (including licenses, covenants or
commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that
would materially interfere with such individual’s ability to render services for the Company or to promote the interest of the
Company or that would conflict with the Company’s business.

 

(b)
Neither the Company nor any of its Subsidiaries engages the services of any individual other than pursuant to a contract of employment
(including any contractor, agency worker or consultant). Each current and employee, consultant and officer of the Company has executed
a customary agreement with the Company regarding ownership of Intellectual Property by the Company and confidentiality and proprietary
information and no employee, consultant or officer is in violation of any agreement described in this Section 5.16(b).

 

    	21

    	 

    

 

(c)
The entry into and performance of this agreement and all other Transaction Documents will not result in any payment or other benefit
to any officer or employee of the Company or any of its Subsidiaries or entitle any such officer or employee to give notice to terminate
his/her contract of employment.

 

(d)
No employee of the Company or any of its Subsidiaries has given or received notice terminating his/her contract of employment, nor, in
the Company’s Knowledge, is any such notice pending or threatened.

 

(e)
Each contract between the Company or the Subsidiaries and any of their respective employees can be terminated by the Company (or such
Subsidiary, as applicable) giving three months’ notice or less without giving rise to the making of a payment in lieu of notice
or a claim for damages or compensation for breach of contract.

 

(f)
Neither the Company nor any of its Subsidiaries is involved in any industrial or trade dispute or negotiation with any trade union, works
council or other employee representative body regarding a claim of material importance to the Company (or the respective Subsidiaries),
and to the Company’s Knowledge, none is pending or threatened.

 

(g)
No employee of the Company or its Subsidiaries is subject to a current disciplinary warning or procedure. There is no material outstanding
claim against the Company or its Subsidiaries by any of their current or former officers or employees or by any individual who otherwise
provides or provided services to it, and in the Knowledge of the Company, no such claim is pending or threatened.

 

(h)
In relation to their current and former officers and employees, each of the Company and its Subsidiaries has complied in all material
respects with all Requirements of Law, Applicable Law, codes of conduct, Workplace Agreements and terms and conditions of employment
and has maintained adequate and suitable records.

 

Section
5.17 Patents, Trademarks, Etc.

 

(a)
The Company and each Subsidiary legally and beneficially owns and/or has the subsisting licenses, permissions or any other contract rights
to use all Intellectual Property material to the conduct of its business (collectively, “IP Rights”) without any known conflict
with or known infringement of the IP Rights of others. Schedule 5.17(a) sets forth a complete list of Licenses or other Contractual Obligations
relating to the Company’s IP Rights (other than off the shelf computer software and programs and Licenses and Contractual Obligations
entered in the ordinary course of business) and of registrations of patents, Trademarks and copyrights including any applications therefor
with respect to such IP Rights. Except as set forth in Schedule 5.17(a), neither the Company nor any Subsidiary has any obligation to
pay any royalty with respect to the IP Rights.

 

(b)
Except as set forth in Schedule 5.17(b), no claims have been asserted by any Person with respect to the use by the Company or any Subsidiary
of any such IP Rights or challenging or questioning the validity or effectiveness of any License or agreement held by the Company or
its Subsidiaries or to which it is a party relating to any such IP Rights. To the Knowledge of the Company, the conduct of the business
of the Company and its Subsidiaries as conducted does not conflict with or infringe upon the IP Rights of others, and neither the Company
nor any Subsidiary has received any communication alleging any such violation. To the Knowledge of the Company, no third party is infringing
or violating any of the IP Rights of the Company or its Subsidiaries. To the Knowledge of the Company, no person employed by or affiliated
with the Company or its Subsidiaries has violated any confidential relationship that such person may have had with any third party, in
connection with the development or sale of any product or service or proposed product or service of the Company or its Subsidiaries.

 

    	22

    	 

    

 

(c)
None of the Company’s or any Subsidiary’s products contain any code or feature that intentionally: (i) disrupts the operation
of any software, firmware, hardware, computer system or network, (ii) permits any Person to access software or data in an unauthorized
manner, or (iii) deletes, damages or corrupts any personal information, data, or communications.

 

(d)
Except as disclosed on Schedule 5.17(d) (which schedule shall, for the avoidance of doubt, list the aggregate amounts, if any, due and
owing to any Person), to the Knowledge of the Company, no IP Rights of the Company or any of its Subsidiaries is subject to any third
party rights (including the payment of royalties), restriction, constraint, control, supervision or limitation as a result of the receipt
or use by the Company or any of its Subsidiaries, respective current or former directors, officers, employees or independent contractors
of any funding, facilities, personnel in the development of any IP Rights of the Company or any of its Subsidiaries.

 

(e)
The Company and its Subsidiaries are, and at all times have been in the past four(4) years preceding the date hereof, in compliance,
in all material respects, with (i) all applicable federal, state, local and foreign laws, rules and regulations governing (A) data security
and cyber security, (B) the collection, storage, use, access, disclosure, processing, security, and transfer of Personal Data (referred
to collectively in this Agreement as “Data Activities”), such as, to the extent applicable, the Regulation (EU) 2016/679
of the European Parliament and of the Council (General Data Protection Regulation) and any European Union member state law implementing
said regulation, and (C) the use of Personal Data in sales or marketing, and electronic communications, such as, to the extent applicable,
the CAN-SPAM Act, the Telephone Consumer Protection Act, and the Telemarketing Sales Rule ((A), (B) and (C) together “Privacy Laws”);
(ii) requirements of self-regulatory programs, including for online behavioral advertising which the Company or a Subsidiary has participated
in; and (iii) all contracts (or portions thereof) to which the Company or a Subsidiary is a party that govern Data Activities, such as,
to the extent applicable, the Company’s and its Subsidiaries’ contractual commitments to third party analytics and advertising
providers (collectively, “Privacy Agreements”).

 

(f)
The Company and its Subsidiaries are, and at all times have been in the past four (4)
years preceding the date hereof, in compliance, in all material respects, to the extent applicable to the Company and its Subsidiaries,
with the PCI Security Standards Council’s Payment Card Industry Data Security Standard (PCI-DSS) and all other applicable security
rules and requirements as promulgated by the PCI Security Standards Council, by any member thereof, or by any entity that functions as
a card brand, card association, card network, payment processor, acquiring bank, merchant bank or issuing bank, such as, to the extent
applicable to the Company and its Subsidiaries, all merchant- and service provider-specific requirements, and the Payment Application
Data Security Standards (PA-DSS) and all applicable audit, scanning and filing requirements (collectively, “PCI Requirements”).

 

(g)
The Company and its Subsidiaries have implemented written policies relating to Data Activities, including, without limitation, a publicly
posted website privacy policy, mobile app privacy policy, and a commercially reasonable information security program that includes commercially
reasonable written information security policies (“Privacy and Data Security Policies”). The Company and its Subsidiaries
are and at all times have been, in the past four (4) years preceding the date hereof, in compliance, in all material respects, with all
such Privacy and Data Security Policies and the Company and its Subsidiaries do not engage in any undisclosed Personal Data collection
on their websites or any third- party websites, except as would not, individually or in the aggregate, reasonably be expected to result
in liability material to the Company. To the Knowledge of the Company, neither the execution, delivery, or performance of this Agreement,
nor the consummation of any of the transactions contemplated under this Agreement will violate, in any material respect, any applicable
Privacy Agreements, Privacy and Data Security Policies, PCI Requirements or Privacy Laws.

 

    	23

    	 

    

 

(h)
Except as would not, individually or in the aggregate, reasonably be expected to result in liability material to the Company, the Company
and its Subsidiaries have provided notifications to, and have obtained consent from, Persons regarding their Data Activities, including
with respect to the Company and its Subsidiaries sharing Personal Data in relation to the transactions contemplated by this Agreement,
where such notice or consent is required by applicable Privacy Laws or contract by which the Company or a subsidiary is legally bound.
To the Knowledge of the Company, the Company and its Subsidiaries have not (i) received direct written communication from any website
owner or operator that the Company’s or its Subsidiaries’ access to such website is unauthorized; (ii) violated in any material
respect any written agreement with any material website owner or operator prohibiting scraping activity; (iii) accessed any website’s
information through illicitly circumventing a password requirement or similar technological barrier; or (iv) scraped any data from a
website that has a clickwrap agreement prohibiting such activity. The Company and its Subsidiaries have all necessary consents and permissions
with respect to the information processed by or on behalf of the Company and its Subsidiaries to permit the Purchaser to use, through
the Company and its Subsidiaries, such data consistent with the Company and its Subsidiaries’ current operations.

 

(i)
To the Knowledge of the Company, there is no pending, nor has there ever been in the past four (4) years preceding the date hereof any,
written complaint, audit, proceeding, investigation, or written claim against the Company or a Subsidiary initiated by (i) any Person;
(ii) the United States Federal Trade Commission or any state attorney general; (iii) any other governmental entity, foreign or domestic;
or any regulatory or self-regulatory entity that has jurisdiction over the Company or its Subsidiaries – alleging that any Data
Activity of the Company or a Subsidiary materially violates any applicable Privacy Laws, Privacy Agreements, Privacy and Data Security
Policies or PCI Requirements.

 

(j)
The Company and its Subsidiaries have taken, in the past four (4) years preceding the date hereof, all commercially reasonable steps
designed to protect Personal Data, or customer data, in their possession or control against damage, loss, and against unauthorized access,
acquisition, use, modification, disclosure or other misuse. To the Knowledge of the Company, in the past four (4) years preceding the
date hereof, there has been no unauthorized access, damage, or modification to, or use, acquisition, loss or disclosure of, Personal
Data, or customer data in the possession or control of the Company or any of its Subsidiaries, except as would not, individually or in
the aggregate, reasonably be expected to result in liability material to the Company. The Company and its Subsidiaries have taken, in
the past four (4) years preceding the date hereof, commercially reasonable steps and implemented commercially reasonable measures and
procedures designed to maintain the Company Systems free from malware and other harmful code, such as, through the use of commercially
available antivirus software. To the Knowledge of the Company, except as would not, individually or in the aggregate, reasonably be expected
to result in liability material to the Company, there have been, in the past four (4) years preceding the date hereof, no successful
unauthorized intrusions or breaches of the security of Company Systems.

 

(k)
Except as would not, individually or in the aggregate, reasonably be expected to result in liability material to the Company, the Company
and its Subsidiaries contractually require all third parties, such as vendors, affiliates, and other persons providing services to the
Company or its Subsidiaries that have access to or receive Personal Data from or on behalf of the Company or its Subsidiaries to comply
with all applicable Privacy Laws, and to take commercially reasonable steps designed to protect Personal Data in such third parties’
possession or control against damage, loss, and against unauthorized access, acquisition, use, modification, disclosure or other misuse.

 

    	24

    	 

    

 

(l)
Except as set forth on Schedule 5.17(f) or with respect to “shrink wrap” or similar licenses of off the shelf software, to
the Knowledge of the Company, all Company Owned Intellectual Property and Company Source Code are wholly and exclusively owned by the
Company, except, in the case of Company Source Code, for any third party Intellectual Property contained therein to which the Company
has a license or valid right to use free and clear of all options, rights, licenses, restrictions and Liens (except for Permitted Liens),
and the Company has not sold, transferred, assigned, promised or otherwise disposed of any rights or interests therein or thereto.

 

(m)
Except as set forth on Schedule 5.17(g) or with respect to “shrink wrap” or similar licenses of off the shelf software, to
the Knowledge of the Company, no Person who has licensed Intellectual Property or Software to the Company or any Subsidiary has ownership
rights or license rights to improvements or other amendments made by the Company or any Subsidiary in such Intellectual Property or Software
that is subsequently included in any Company Products, other than with respect to such improvements or other amendments (i) that are
owned by or jointly with the Person who licensed the underlying Intellectual Property or Software to which the Company has a valid license
that is co-extensive with the license to the underlying Intellectual Property or Software or (ii) that are owned by the Company to which
the Person who licensed the underlying Intellectual Property or Software has a non-exclusive license solely to such improvements or other
amendments.

 

(n)
Except as set forth on Schedule 5.17(h) or with respect to “shrink wrap” or similar licenses of off the shelf software, to
the Knowledge of the Company, neither the Company nor any Subsidiary has used any Open Source Materials in a manner that results in the
grant of or requires the Company or a Subsidiary to grant a license to or disclose the Company Source Code.

 

(o)
Neither the Company nor any Subsidiary has granted to any third party a license to any Company Owned Intellectual Property (other than
standard non-exclusive end user licenses provided in the ordinary course of business).

 

(p)
In the three (3) years prior to the date hereof, the Company and its Subsidiaries have not received written notice alleging them to be
in material breach or default of any agreements (i) to which the Company or a Subsidiary is a party, and (ii) pursuant to which the Company
or a Subsidiary is granted the right to use any third Person’s Intellectual Property. Except as disclosed on Schedule 5.17(d),
during the three (3) years prior to the Closing Date, neither the Company Owned Intellectual Property (including any use thereof) nor
the conduct of the Company’s and its Subsidiaries’ business has infringed upon or misappropriated the Intellectual Property
of any Person, other than matters resolved by the Company in the ordinary course of business; provided that with respect to (A) infringement
of patents, and (B) infringement or misappropriation related to third party music or content displayed through the Company’s or
its Subsidiaries’ applications, such representation is made only to the Knowledge of the Company.

 

Section
5.18 Potential Conflicts of Interest. Except as set forth on Schedule 5.18, to the knowledge of the Company, no member of Senior
Management or shareholder of the Company or any Subsidiary: (a) is an officer, director, manager, employee or consultant of, any Person
that is, or is engaged in business as, a competitor, lessor, lessee, supplier, distributor, sales agent or customer of, or lender to
or Company from, the Company or its Subsidiaries; (b) has been a party to any transaction with the Company or any Subsidiary; (c) owns,
directly or indirectly, in whole or in part, any tangible or intangible property that the Company or its Subsidiaries uses or contemplates
using in the conduct of business; or (d) has any cause of action or other claim whatsoever against, or owes or has advanced any amount
to the Company or any Subsidiary, except for advances in the ordinary course of business for accrued vacation pay, accrued benefits under
employee benefit plans, customary expense reimbursements existing on the date hereof, and similar matters and agreements.

 

    	25

    	 

    

 

Section
5.19 Indebtedness. Schedule 5.19 lists (a) the amount of all Indebtedness of the Company and its Subsidiaries (other than Indebtedness
under this Agreement) that is in existence immediately before the Closing Date and will remain outstanding immediately after the Closing
Date, (b) the Liens that relate to such Indebtedness and that encumber
the assets of the Company or any of its Subsidiaries, (c) the name of each lender thereof, and (d) the amount of any unfunded commitments,
if any, available to the Company and its Subsidiaries in connection with any such Indebtedness facilities.

 

Section
5.20 Material Contracts. Schedule 1.1(a) lists all Material Contracts. Except as set forth on Schedule 5.20, each of the Material
Contracts is in full force and effect. Except as set forth on Schedule 5.20, the Company and its Subsidiaries have satisfied in full
or provided for all of its liabilities and obligations under each Material Contract requiring performance prior to the date hereof, and
is not in default under any of such Material Contracts, nor does any condition exist that with notice or lapse of time or both would
constitute such a default. To the Knowledge of the Company, no other party to any Material Contract is in default thereunder, nor does
any condition exist that with notice or lapse of time or both would constitute such a default. Other than as set forth in Section 2.6(a)(iv)
or Schedule 2.6(a)(vii), no approval or consent of any Person is needed for the Material Contracts to continue to be in full force and
effect after giving effect to the Transaction.

 

Section
5.21 Insurance. Schedule 5.21 accurately summarizes all of the insurance policies or programs of the Company and its Subsidiaries
as of the date hereof, with respect to the operation of Company’s business activities. All such policies are in full force and
effect are underwritten by reputable insurers, are sufficient for all applicable Requirements of Law. All such policies will remain in
full force and effect and will not terminate or lapse by reason of any of the Transaction.

 

Section
5.22 Solvency. The Company and each Subsidiary is Solvent before and after taking into account the Transaction.

 

Section
5.23 Licenses and Approvals. The Company and each of its Subsidiaries holds all material Licenses that are required by any Governmental
Authority to permit them to conduct and operate their businesses as now conducted, and all such Licenses are valid and in full force
and effect and will remain in full force and effect upon consummation of the Transaction. Except as would not reasonably be expected
to have a Material Adverse Effect, (i) the Company and its Subsidiaries are in compliance in all material respects with all material
Licenses and (ii) there is no pending threat of cancellation, loss, termination, modification, or nonrenewal of any such Licenses of
the Company or its Subsidiaries, nor any basis for such cancellation, loss, termination, modification, or nonrenewal.

 

Section
5.24 OFAC; Anti-Terrorism; Patriot Act. Neither the Company nor any Subsidiary nor any Affiliate of Company: (a) is a Sanctioned
Person, (b) has any assets in Sanctioned Entities, or (c) derives any operating income from Investments in, or transactions with Sanctioned
Persons or Sanctioned Entities. The proceeds of the sale will not be used and have not been used to fund any operations in, finance any
investments or activities in, or make any payments to, a Sanctioned Person or a Sanctioned Entity. The Company and its Subsidiaries are
in compliance, with any United States Requirements of Law relating to terrorism, sanctions or money laundering (the “Anti-Terrorism
Laws”), including the United States Executive Order No. 13224 on Terrorist Financing (the “Anti-Terrorism Order”) and
the Patriot Act. No part of the proceeds of the sale of the Purchased Shares will be used, directly or indirectly, for any payments to
any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else
acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United
States Foreign Corrupt Practices Act of 1977, as amended or any other Anti-Terrorism Law. Neither the Company nor any Subsidiary nor
any Affiliate of the Company (i) is listed in the annex to, or is otherwise subject to the provisions of, the Anti-Terrorism Order, (ii)
is owned or controlled by, or acting for or on behalf of, any person listed in the annex to, or is otherwise subject to the provisions
of, the Anti-Terrorism Order or (iii) commits, threatens or conspires to commit or supports “terrorism” as defined in the
Anti-Terrorism Order.

 

    	26

    	 

    

 

Section
5.25 Disclosure. This Agreement, together with all exhibits and schedules hereto, the Transaction Documents, and the agreements,
certificates and other documents specifically contemplated by the Transaction Documents furnished to the Purchaser by the Company at
the Closing, do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
contained herein or therein, in the light of the circumstances under which they were made, not misleading provided that to the
extent any such exhibit, schedule, agreement, certificate or other document was based solely upon or constitutes a forecast or projection,
the Company represents only that it acted in good faith and utilized reasonable assumptions in the preparation of such exhibit, schedule,
agreement, certificate or other document, it being understood that actual results may vary from such forecasts and that such variations
may be material.

 

Section
5.26 Material Adverse Effect. As of the date of this Agreement, there is no fact which the Company has not disclosed to the Purchaser
in writing which would reasonably be expected to have a Material Adverse Effect.

 

Section
5.27 Absence of Certain Practices. Except as set forth on Schedule 5.27, neither Company or any of its Subsidiaries, nor to the
Knowledge of the Company, any director, officer, agent, employee or other Person, has given or agreed to give, in violation of any Applicable
Law (including, without limitation, the US Foreign Corrupt Practices Act of 1977, the Penal Code (Cap. 224) of Singapore, the Prevention
of Corruption Act (Cap. 241) of Singapore, as amended), any gift or similar benefit of more than nominal value to any customer, supplier,
governmental employee or official or any other Person who is or may be in a position to help or hinder Company or its Subsidiaries or
assist Company or any of its Subsidiaries in connection with any proposed transaction involving Company or its Subsidiaries, which gift
or similar benefit, induced any party to do business with the Company or any Subsidiary. Neither the Company nor any Subsidiary, nor
any director, officer, agent, employee or other Person acting on their behalf has (i) used any corporate or other funds for unlawful
contributions, payments, gifts, or entertainment, or made any unlawful expenditures relating to political activity to, or on behalf of,
government officials or others; or (ii) accepted or received any unlawful contributions, payments, gifts or expenditures.

 

Section
5.28 Accounts and Notes Receivable; Accounts and Notes Payable.

 

(a)
Except as set forth in Schedule 5.28, all the accounts receivable and notes receivable owing to Company or any Subsidiary as of the date
hereof constitute valid and enforceable claims (without any previously exercised rights of set off or compromise) arising from bona fide
transactions in the ordinary course of business, consistent with past practice, and, to the Knowledge of the Company, there are no known
or, to the Knowledge of the Company, asserted claims, refusals to pay or other rights of set-off against any thereof. Except as provided
on Schedule 5.28, there is (i) no account debtor or note debtor delinquent in its payment by more than thirty (30) days; (ii) no account
debtor or note debtor that has refused (or, to the Knowledge of the Company, threatened to refuse) to pay its obligations for any reasons;
(iii) to the Knowledge of the Company or any, no account debtor or note debtor that is insolvent or bankrupt other than as set forth
on Schedule 5.28, and (iv) no account receivable or note receivable which is hypothecated or pledged to any person by the Company or
any of its Subsidiaries.

 

    	27

    	 

    

 

(b)
All accounts payable and notes payable by the Company or any of its Subsidiaries to third parties as of the date hereof arise from bona
fide transactions in the ordinary course of business, consistent with past practice and, except as set forth on Schedule 5.28, there
is no such account payable or note payable more than thirty (30) days delinquent in its payment, except those contested in good faith.

 

Section
5.29 Powers of Attorney. Neither the Company nor any of its Subsidiaries has given any power of attorney or similar authority
to any third party which remains in force, authorizing such third party to represent and bind it, either in general or for any special
purposes, other than authorities given to its officers and employees in the normal course of their duties except for any power of attorney
or similar authority publicly registered by the Company (or such Subsidiary, as applicable).

 

Section
5.30 Directors and Executive Officers. To the Knowledge of the Company and its chief executive officer, none of the executive
officers and directors, included in such attached list as set forth in Schedule 5.30 have been charged with, indicted for, been part
of a proceeding for, been investigated for, arrested for, or convicted of a felony, nor are they engaged in criminal activity, nor have
any of them been an officer of a bankrupt company.

 

Section
5.31 Oral Agreements. To the Knowledge of the Company, there are no written or oral side agreements with any individual or business
whereby the Company or its management has agreed to incur any obligations other than those contained in formal written contracts or agreements
executed by or on behalf of the Company.

 

Section
5.32 Access to Information. The Company has made available to the Purchaser all the information reasonably available to the Company
that the Purchaser has requested for deciding whether to acquire the Shares, including all documents and materials that would reasonably
be considered responsive to the representations and warranties of the Company in this Agreement and the Transaction Documents. The corporate
records and books of the Company provided to the Purchaser contains minutes of all meetings of directors and shareholders of the Company,
all actions by written consent without a meeting by the directors and shareholders of the Company in the past 3 years prior to the date
hereof, except for the absence of any such minutes or consents which would not materially and adversely affect the Company, and accurately
reflects in all material respects all actions by the directors (and any committee of directors) and shareholders of the Company. It is
understood that this representation is qualified by the fact that the Company has not delivered to the Purchaser, and has not been requested
to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to
purchasers of securities.

 

ARTICLE
VI

REPRESENTATIONS
AND WARRANTIES OF THE SELLING SHAREHOLDERS

 

Each
Selling Shareholder, for itself and for no other Selling Shareholder, hereby severally and not jointly represents and warrants as of
the date hereof and as of the Closing Date to the Purchaser as follows (unless as of a specific date therein):

 

Section
6.1 Organization; Authority. Such Selling Shareholder is either an individual or an entity duly incorporated or formed, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership,
limited liability company or similar power and authority to enter into and to consummate the Transaction and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by each Selling Shareholder
of the Transaction have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as
applicable, on the part of such Selling Shareholder. Each Transaction Document to which it is a party has been duly executed by such
Selling Shareholder, and when delivered by such Selling Shareholder in accordance with the terms hereof, will constitute the valid and
legally binding obligation of such Seller, enforceable against it in accordance with its terms, except: (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies.

 

    	28

    	 

    

 

Section
6.2 Ownership. Such Selling Shareholder is the sole legal and beneficial owner of the shares set forth opposite such Selling Shareholder’s
name on Exhibit 1 attached hereto (or, in the case of such Selling Shareholder who is a holder of an Outstanding Convertible Note,
such Outstanding Convertible Note as of the date hereof and such Conversion Shares as of immediately prior to the Closing, in each case
set forth opposite such Person’s name on Schedule 1.1(b)), free and clear of any Liens, but subject to the applicable securities
laws and limitations under the organizational documents and the Shareholders Agreement of the Company then in effect and together with
all rights of any nature attached or accruing to them on or after Closing (including the right to receive all dividends and distributions
declared, paid or made by the Company on or after the Closing Date with respect to the Purchased Shares sold by such Selling Shareholder).
Such Selling Shareholder has not been granted, nor has it entered into any agreement to grant any rights of whatever kind or nature to
acquire additional shares of the Companies equity securities. Such Selling Shareholder is entitled to transfer the legal and beneficial
ownership of the shares set forth opposite such Selling Shareholder’s name on Exhibit 1 attached hereto (or, in the case
of such Selling Shareholder who is a holder of an Outstanding Convertible Note, such Outstanding Convertible Note as of the date hereof
and such Conversion Shares as of immediately prior to the Closing, in each case set forth opposite such Person’s name on Schedule
1.1(b)) to the Purchaser on the terms set out herein. Such Selling Shareholder has the right to exercise all voting and other rights
over the shares set forth opposite such Selling Shareholder’s name on Exhibit 1 attached hereto (or, in the case of such
Selling Shareholder who is a holder of an Outstanding Convertible Note, with respect to the Conversion Shares as of immediately prior
to the Closing set forth opposite such Person’s name on Schedule 1.1(b)).

 

Section
6.3 No Conflict. Neither the execution and delivery of this Agreement or any other Transaction Document to be executed and delivered
in connection herewith by such Selling Shareholder, nor the consummation of the Transaction contemplated hereby or thereby, nor the fulfilment
by such Selling Shareholder of any of the terms contemplated hereby or thereby will, conflict with or result in a breach by such Selling
Shareholder of, or constitute a default under, or create an event that, with the giving of notice or the lapse of time, or both, would
be a default under or breach of, or give a right to terminate, accelerate, modify or cancel under, any of the terms, conditions or provisions
of (i) to the extent such Selling Shareholder is an entity, the formation and governing documents of such Selling Shareholder, or (ii)
any judgment, order, writ, injunction, decree or demand of any governmental entity to which such Selling Shareholder or the shares of
Company capital such Selling Shareholder owns, is subject.

 

Section
6.4 Litigation. There are no Proceedings pending or, to the knowledge of the Selling Shareholder, threatened, at law, in equity,
in arbitration or before any Governmental Authority against or affecting the Selling Shareholder seeking to restrain, prevent or change
the Transaction Transactions or questioning the validity or legality of the Transaction Documents to which such Selling Shareholder is
a party or that could reasonably be expected to have, individually or in the aggregate, a material adverse effect on the Selling Shareholder’s
ability to enter into and deliver any Transaction Documents to which it is a party and perform its obligations therein. There is no injunction,
writ, temporary restraining order, decree or any order or determination of any nature by any arbitrator, court or other Governmental
Authority purporting to enjoin or restrain the execution, delivery or performance of the Transaction Documents by the Selling Shareholder.

 

    	29

    	 

    

 

Section
6.5 Conversion of Outstanding Convertible Notes. Such Selling Shareholder, to the extent that such Selling Shareholder is a holder
of an Outstanding Convertible Note agrees to convert all of the principal amount outstanding under such Outstanding Convertible Note
into Conversion Shares in connection with the Transaction for sale of all of such Conversion Shares to the Purchaser at Closing, hereby
agrees that the entire amount owed by the Company to such Selling Shareholder under such Outstanding Convertible Note is being tendered
to the Company in exchange for the applicable Conversion Shares set forth on Schedule 1.1(b) and, effective upon the Closing, without
any further action required by the Company or such Selling Shareholder, such Outstanding Convertible Note and all obligations set forth
therein shall be immediately deemed satisfied in full and terminated in their entirety.

 

ARTICLE
VII

REPRESENTATIONS
AND WARRANTIES OF THE PURCHASER

 

The
Purchaser hereby represents and warrants as of the date hereof and as of the Closing Date to the Company and each Selling Shareholder
as follows (unless as of a specific date therein):

 

Section
7.1 Organization and Qualification. Purchaser is duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted or is currently proposed to be, engaged. Purchaser has the corporate power
and authority to execute, deliver and perform its obligations under this Agreement and other Transaction Documents to which it is or
will be a party and otherwise to carry out its obligations hereunder and thereunder.

 

Section
7.2 Authorization; Binding Effect. The execution and delivery of the Transaction Documents and performance by the Purchaser of
the Transaction have been duly authorized by all necessary corporate power on the part of the Purchaser, and each Transaction Document
to which it is a party has been or will be, at Closing, duly executed by the Purchaser, and when delivered by the Purchaser in accordance
with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally and (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies

 

Section
7.3 No Conflicts. The execution, delivery and performance of this Agreement and performance under the other Transaction Documents
and the consummation by Purchaser of the Transaction contemplated hereby and thereby or relating hereto or thereto do not and will not
(i) result in a violation of the Purchaser charter documents, bylaws or other organizational documents, if applicable, (ii) conflict
with nor constitute a default (or an event which with notice or lapse of time or both would become a default) under any agreement to
which Purchaser is a party, nor (iii) result in a violation of any law, rule, or regulation, or any order, judgment or decree of any
court or governmental agency applicable to such Purchaser or its properties (except for such conflicts, defaults and violations as would
not, individually or in the aggregate, have a material adverse effect on Purchaser). Purchaser is not required to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver
or perform any of its obligations under this Agreement or perform under the other Transaction Documents nor to purchase the Purchased
Shares in accordance with the terms hereof, provided that for purposes of the representation made in this sentence, such Purchaser is
assuming and relying upon the accuracy of the relevant representations and agreements of the Company herein.

 

    	30

    	 

    

 

Section
7.4 Litigation. There are no Proceedings pending or, to the knowledge of the Purchaser, threatened, at law, in equity, in arbitration
or before any Governmental Authority against or affecting the Purchaser seeking to restrain, prevent or change the Transaction or questioning
the validity or legality of the Transaction Documents or that could reasonably be expected to have, individually or in the aggregate,
a material adverse effect on the Purchaser’s ability to enter into and deliver any Transaction Documents and perform its obligations
therein. There is no injunction, writ, temporary restraining order, decree or any order or determination of any nature by any arbitrator,
court or other Governmental Authority purporting to enjoin or restrain the execution, delivery or performance of the Transaction Documents
by the Purchaser or which relates to the assets or the business of the Purchaser.

 

Section
7.5 Understandings or Arrangements. The Purchaser understands that the Purchased Shares are “restricted securities”
and have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or any applicable state
securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling
such Purchased Shares or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention
of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right
to sell the Purchased Shares pursuant to a registration statement or otherwise in compliance with applicable Singapore or other relevant
jurisdictions laws). Purchaser is acquiring the Securities hereunder in the ordinary course of its business.

 

Section
7.6 Accredited Investor. The Purchaser is an accredited investor as defined in Section 4A of the Securities and Futures Act (Chapter
289) of Singapore, as amended and in Rule 501(a) of Regulation D promulgated under the Securities Act.

 

Section
7.7 Information on Company. Purchaser has been furnished with or has had access to the Company’s books and records, website,
and documents and financial data. Subject to and conditioned upon the accuracy of the representations and warranties of the Company and
the Selling Shareholders set forth in this Agreement and the Transaction Documents (including, without limitation, Section 5.32), Purchaser
believes that it has received or had access to all the information Purchaser considers necessary or appropriate for deciding whether
to purchase the Purchased Shares and Purchaser was afforded (i) the opportunity to ask such questions as deemed necessary of, and to
receive answers from representatives of the Company concerning the merits and risks of acquiring the Purchased Shares to be purchased
from the Selling Shareholders; (ii) the right of access to information about the Company and its financial condition, results of operations,
business, properties, management and prospects sufficient to enable such Purchaser to evaluate the Purchased Shares; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision Purchaser is not relying on any statements or representations of the Company or its agents for
legal advice with respect to this investment or the Transaction.

 

Section
7.8 Solvency. The Purchaser is Solvent before and after taking into account the Transaction.

 

    	31

    	 

    

 

ARTICLE
VIII

PRE-CLOSING
COVENANTS

 

Section
8.1 Conduct of Business. From the date of this Agreement until the earlier of (x) the Long Stop Date, (y) any material non-performance
or material breach of this Agreement by the Purchaser (including without limitation any failure to pay the Additional Interim Payment
to the Company), or (z) the Closing (together with (x) and (y), the “Restricted Period”), the Company will, and will cause
any Subsidiary to, carry on and conduct its business in substantially the same manner and in substantially the same fields of enterprise
as it is presently conducted or those reasonably related or ancillary thereto (the “Business”) and do all things necessary
to remain duly incorporated validly existing and in good standing as a domestic corporation in its jurisdiction of incorporation and
maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted except to the extent
the failure to be so qualified could not reasonably be expected to have a Material Adverse Effect. Without prejudice to the foregoing,
during the Restricted Period, other than (I) to satisfy, or as otherwise contemplated by, the terms and conditions of this Agreement
and any agreements contemplated hereby (including without limitation, adopting the A&R Shareholders Agreement, modifying the Board
structure as contemplated in advance of the Closing, and modifying the constitution of the Company to facilitate the Transaction, by
the A&R Shareholders Agreement or by the other Transaction Documents, or entering into an amendment to the UMG Agreement pursuant
to Section 2.6(a)(iv), provided that the form of such amendment shall be subject to the Purchaser’s consent, which such consent
shall not be unreasonably withheld, conditioned or delayed), (II) the
granting of options or updating the share structure upon the exercise of options under the Company’s ESOP scheme or as set forth
in Schedule 1.1(d), the conversion of any outstanding convertible promissory notes or warrant into Shares, or (III) in the ordinary course
of business, absent the express advance written consent of the Purchaser, neither the Company nor any of its Subsidiaries shall or shall
agree to (whether conditionally or not):

 

(a)
change its issued share capital in any way (including the creation of new shares, the redemption or repurchase of shares or any reduction
of capital) or grant any option or right to subscribe for any shares or other securities convertible into shares;

 

(b)
change any rights attached to any of its shares;

 

(c)
declare, pay or make any dividend or other distribution or capitalize any reserves;

 

(d)
change its constitutional or governing documents, other than as set forth in Schedule
8.1;

 

(e)
pass any resolution of its shareholders or any class of its shareholders, other than as set forth in Schedule 8.1;

 

(f)
change its auditors, the date to which its annual accounts are prepared or its accounting principles, procedures or practices;

 

(g)
enter into any kind of insolvency process or any arrangement with its creditors

generally;

 

(h)
undertake any merger, demerger or any other kind of business combination or reorganization;

 

(i)
acquire or dispose of:

 

(i)
any shares or any other interest in any company, business or partnership;

 

(ii)
any real property or interest in real property; or

 

    	32

    	 

    

 

(iii)
any other material asset (except current assets in the ordinary course of business);

 

(j)
grant any interest in any real property or vary the terms of, or waive any rights under, any lease of real property (including settling
any rent review);

 

(k)
create any Lien over any of its assets or undertaking (except in the ordinary course of trading or any Permitted Liens);

 

(l)
enter into, amend or terminate any material agreement or arrangement with the Sellers (other than in the ordinary course of business
on arm’s length terms or as set forth in Schedule 8.1);

 

(m)
incur any borrowings (except borrowings in the ordinary course of business not exceeding Two Hundred Fifty Thousand Dollars ($250,000));

 

(n)
make any loan (except to employees or other Subsidiaries or the Company) or grant any credit (except trade credit in the ordinary course
of business);

 

(o)
waive any amounts owed to it by, or any rights it has against, the Sellers;

 

(p)
enter into, materially amend or terminate any joint venture or partnership arrangement;

 

(q)
give any guarantee or indemnity in relation to the obligations or liabilities of any other
person;

 

(r)
commence or settle any dispute or legal or arbitral proceedings involving an amount in excess of One Hundred Thousand Dollars ($100,000)
(except when required by insurers), or waive any right in relation to any such dispute or proceedings;

 

(s)
appoint or remove any of its Senior Management;

 

(t)
make any material changes to the terms and conditions of employment (including remuneration and benefits) of any of its Senior Management;

 

(u)
enter into, amend or terminate any collective agreements or other arrangements with any trade union, works council or other employees’
representative body;

 

(v)
establish, participate in or contribute to any new pension scheme or grant any new retirement, death or disability benefit; or

 

(w)
change, discontinue or exercise any discretion in relation to any existing pension scheme or retirement, death or disability benefit,
or announce any plan, proposal or intention to do so, provided that the foregoing shall not restrict the Company or its Subsidiaries
from doing anything (x) required by, or to give effect to, any Transaction Documents; (y) the Purchaser’s prior written consent;
or (z) to comply with any Applicable Law.

 

Section
8.2 Compliance with Laws and Material Agreements. During the Restricted period, the Company will, and will cause each of its Subsidiaries
to, comply with any and all Requirements of Law to which it may be subject, and obtain any and all Licenses necessary to the ownership
of its Property or to the conduct of its businesses. During the Restricted Period, the Company will and will cause each of its Subsidiaries
to, timely satisfy all material assessments, fines, costs and penalties imposed by any Governmental Authority against it or its Property
except to the extent such assessments, fines, costs, or penalties are being contested in good faith by appropriate proceedings and for
which the Company or such Subsidiaries has set aside on its books adequate reserves in accordance with SFRS.

 

    	33

    	 

    

 

Section
8.3 Maintenance of Properties. During the Restricted Period, the Company will, and will cause each of its Subsidiaries to, do
all things necessary to maintain, preserve, protect and keep its Property (other than Property that is obsolete, surplus, or no longer
used or useful in the ordinary conduct of its business) in good repair, working order and condition (ordinary wear and tear and casualty
and condemnation excepted), make all necessary and proper repairs, renewals and replacements such that its business can be carried on
in connection therewith and be properly conducted at all times and pay and discharge when due the cost of repairs and maintenance to
its Property, and pay all rentals when due for all real estate leased by such Person.

 

Section
8.4 Cooperation Regarding Structure. During the Restricted Period, the parties hereto agree to cooperate toward structuring drafting
the Transaction Documents, including, but not limited to, possible modifications to the Company’s corporate structure, in a manner
that is tax efficient to the parties.

 

Section
8.5 Further Assurances. During the Restricted Period, the Company will, and will cause each of its Subsidiaries to, take any action
reasonably requested by the Purchaser in order to effectuate the purposes and terms contained in this Agreement or any of the Transaction
Documents.

 

Section
8.6 Approvals and Waivers.

 

(a)
By entering into this Agreement, each Selling Shareholder hereby approves the Transaction pursuant to their approval rights under the
Shareholders Agreement and the Constitution and waives any other rights they may have under the Shareholders Agreement or the Constitution
in connection with such Transaction, in each case to the extent legally permissible. To the extent applicable, during the Restricted
Period, each Selling Shareholder shall exercise its voting rights and powers available to it, and shall procure its appointed Directors
(as the case may be) to approve such resolutions, as may be necessary to implement the transfer of the Purchased Shares and the issuance
of the convertible notes in connection with the Signing Payment, the Additional Interim Payment and, if paid, the Additional Payment,
to the Purchaser. In furtherance of the foregoing, each Selling Shareholder hereby irrevocably and unconditionally (i)
consents to the completion of the Transaction contemplated in this Agreement and any other Transaction Documents, (ii) waives any anti-dilution
right, preemptive right, right of first refusal, co-sale right, transfer restrictions, protective rights or other similar rights with
respect to the Transaction contemplated in this Agreement any other Transaction Documents, and waives any applicable notice periods that
it may be entitled to with respect to such transactions, whether such rights or notice periods are provided for under any contract to
which such shareholder is a party or under the Constitution or the Shareholders Agreement, and (iii) acknowledges and agrees that the
Transaction contemplated in this Agreement and any other Transaction Documents shall not constitute a Liquidation Event as defined in
the Constitution.

 

(b)
By entering into this Agreement, each Selling Shareholder hereby agrees and acknowledges that the issuance of the additional options
set forth under the column “Issued Options (immediately prior to Closing)” in Schedule 1.1(d) has been duly approved or ratified
by such Selling Shareholder pursuant to their approval rights under the Shareholders Agreement and the Constitution. Further, each Selling
Shareholder hereby waives any rights it may have under the Shareholders Agreement or the Constitution in connection with such issuance;
provided, however, that the Terminated Options set forth in Schedule 1.1(d) for Gene Tan shall be deemed issued to him at Closing with
the right to receive payment under Section 2.1(c), and only the difference between his Issued Options (immediately prior to Closing)
and Terminated Options, each as set forth on Schedule 1.1(d), shall be actually issued immediately prior to Closing.

 

    	34

    	 

    

 

(c)
Subject to the consummation of the Closing pursuant to this Agreement, each Selling Shareholder hereby elects to convert all Preference
Shares held by it into Ordinary Shares effective immediately upon the Closing, such conversion to occur at such time without any further
action on the part of the Company or the Selling Shareholders. During the Restricted Period, each Selling Shareholder hereby agrees to
vote at any meeting of the shareholders of the Company, and to act by written consent of the shareholders of the Company, against any
action, agreement, transaction or proposal that would cause a material breach of any covenant, representation, warranty or other obligation
or agreement of the Company under this Agreement or that would reasonably be expected to frustrate, prevent or interfere with the Closing.

 

(d)
During the Restricted Period, each Selling Shareholder agrees, and will cause its representatives, to take any action reasonable requested
by the Purchaser in order to effectuate the purposes and terms contained in this Agreement and the Transaction Documents.

 

(e)
Each Selling Shareholder agrees that, during the Restricted Period, and subject to the consummation of the Closing pursuant to this Agreement,
if the Company or the Purchaser is unable, due to such Selling Shareholder’s unavailability, dissolution, mental or physical incapacity,
or for any other reason, to secure such Selling Shareholder’s signature with respect to any stock assignment or instrument of transfer
required to be executed by such Selling Shareholder pursuant to the terms and conditions of this Agreement to effect the Closing, then
such Selling Shareholder hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as such Selling
Shareholder’s agent and attorney- in-fact, to act for and on such Selling Shareholder’s behalf to execute and file such stock
assignment or instrument of transfer with the same legal force and effect as if executed by such Selling Shareholder. This power of attorney
shall be deemed coupled with an interest, and shall be irrevocable during the Restricted Period. Each Party further agrees and acknowledges
that this Agreement may be shared with a third party with the mutual consent of the Company and the Purchaser, for purposes of effecting
the power of attorney given by each such Selling Shareholder in this provision.

 

Section
8.7 Public Announcement. Neither party hereto shall make any public announcement in connection with the Transaction Documents
or the Transaction, without the prior written consent of each other party hereto, provided that the Company and the Purchaser shall have
the right to make such public announcement with the prior written consent of each other, for so long they do not use the name or trademark
of any Selling Shareholder without the prior written consent of such Selling Shareholder. The Company and the Purchaser shall provide
each other a reasonable opportunity to review and comment on the public announcement prepared by such party.

 

Section
8.8 Termination of Shareholders Agreements, Related Agreements. Subject to the consummation of the Closing pursuant to the Agreement,
each Selling Shareholder, severally and not jointly, hereby agrees that the following shall terminate effective immediately upon the
Closing: (a) the Shareholders Agreement;; and (b) if applicable to any Selling Shareholder, any rights under any letter agreement providing
for redemption rights, voting rights, approval rights, put rights, purchase rights or other similar rights not generally available to
shareholders of the Company between such Selling Shareholder and the Company, but excluding, for the avoidance of doubt, any rights such
Selling Shareholder may have that relate to any commercial, employment or indemnification agreements or similar arrangements between
such Selling Shareholder and the Company or any subsidiary, which shall survive in accordance with their terms.

 

    	35

    	 

    

 

Section
8.9 Transfer of Shares. Each Selling Shareholder, severally and not jointly, agrees that during the Restricted Period, it shall
not, directly or indirectly, (a) sell, assign, transfer (including by operation of law), create any Lien or pledge, dispose of or otherwise
encumber any of its Shares or otherwise agree to do any of the foregoing, except for a sale, assignment or transfer pursuant to the Agreement
or to another shareholder of the Company that is a party to this Agreement and bound by the terms and obligations hereof, (b) deposit
any Shares into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto
that would frustrate the purpose of this Agreement or (c) enter into any contract, option or other arrangement or undertaking with respect
to the direct acquisition or sale, assignment, transfer or other disposition of any Shares, except as set forth in the Shareholders’
Agreement; provided, that the foregoing shall not prohibit the transfer of any Shares to an affiliate of a Selling Shareholder, but only
if such affiliate of such Selling Shareholder shall execute this Agreement or a joinder agreeing to become a party to this Agreement.

 

Section
8.10 No Solicitation of Transactions. Each of the Selling Shareholders severally and not jointly, agrees during the Restricted
Period not to directly or indirectly, through any officer, director, representative or agent of the Company, (a) solicit, initiate or
knowingly encourage (including by furnishing information) the submission of, or participate in any discussions or negotiations regarding,
any transaction in violation of the Agreement or (b) participate in any discussions or negotiations regarding, or furnish to any person
or other entity or “group” of affiliated persons, any information with the intent to, or otherwise cooperate in any way with
respect to, or knowingly assist, participate in, facilitate or encourage, any unsolicited proposal that constitutes, or may reasonably
be expected to lead to, an alternative transaction or series of transactions that would frustrate, prevent or interfere with the consummation
of the transactions contemplated by this Agreement or the Closing (an “Alternative Transaction”). During the Restricted Period
each Selling Shareholder shall, and shall direct its representatives and agents to, immediately cease and cause to be terminated any
discussions or negotiations with any parties that may be ongoing with respect to any Alternative Transaction. If during the Restricted
Period, any Selling Shareholder receives any inquiry or proposal with respect to an Alternative Transaction, then such Selling Shareholder
shall promptly (and in no event later than twenty-four (24) hours after such Selling Shareholder becomes aware of such inquiry or proposal)
notify such person in writing that the Company is subject to an exclusivity agreement with respect to the sale of the Company that prohibits
such Selling Shareholder from considering such inquiry or proposal.

 

Section
8.11 Reversion of Rights in the Event of No Closing. For the avoidance of doubt, in the event that any of the following actions
have been taken by the Selling Shareholders in anticipation of Closing, and this Agreement is subsequently terminated or the Closing
is not otherwise consummated, then such actions shall be rescinded as if each such action had not occurred and the Company, the Purchaser
and the Selling Shareholders will cooperate to ensure that all rights, preferences and privileges of the Selling Shareholders attaching
to the Preference Shares, whether pursuant to the Shareholders Agreement or the Constitution or otherwise, shall revert in full: (a)
any conversion of Preference Shares into Ordinary Shares;(b) any of the
actions, approvals, waivers or other matters contemplated by Sections 8.6 and/or 8.8; (c) any conversion of Outstanding Convertible Notes
outstanding as of the date hereof unless otherwise consented to by the holder of such Outstanding Convertible Note; and (d) any other
action taken pursuant to this Agreement in anticipation of or in connection with the Closing that was for purposes of consummating the
Closing.

 

    	36

    	 

    

 

ARTICLE
IX

POST-CLOSING
COVENANTS

 

Section
9.1 Size of the Board; Board Representation. Upon Closing, the Company and the Selling Shareholders shall take all necessary action
to ensure that the Board will consist of five (5) members immediately following the Closing, of which (i) three (3) directors shall be
Purchaser Directors, and (ii) two (2) directors shall be nominees of Paul Yang Zhiwen (“Mr. Zhiwen”), one of whom shall be
Mr. Zhiwen and one of whom shall initially be appointed prior to the Closing. The A&R Shareholders Agreement will provide that the
directors nominated by the Purchaser or Mr. Zhiwen may only be removed at the request of the Purchaser or Mr. Zhiwen, as the case may
be, and that the shareholders of the Company party thereto shall take all necessary actions to facilitate such removal at the request
of the Purchaser or Mr. Zhiwen, as the case may be.

 

Section
9.2 Zhiwen. The A&R Shareholders Agreement will provide that, at all times following Closing, for a period of at least five
(5) years, Mr. Zhiwen shall serve as a director on the Board and a shareholder of the Company, with control over management of the operations
and affairs of the Company, unless otherwise consented to in writing by the Purchaser for as long as the Purchaser holds any shares of
the Company.

 

Section
9.3 Acknowledgement. Each Selling Shareholder hereby further acknowledges that (a) it has been furnished with or has had access
to the Company’s books and records, website, documents, financial data and all the information such Selling Shareholder considers
necessary or appropriate for deciding whether to sell the Purchased Shares, (b) such Selling Shareholder is not relying on any statements
or representations of the Company or its agents for legal advice with respect to this investment or the Transaction, and (c) solely with
respect to the Purchased Shares, such Selling Shareholder shall, after the sale of the Purchased Shares at the Closing, have no rights
as a shareholder of the Company with respect to any future sale, acquisition, merger, liquidation, dissolution, public offering or other
corporate event regarding the Company or its assets (any of the foregoing, a “Corporate Event”) by reason of such Selling
Shareholder’s ownership of the Purchased Shares prior to the transfer of the Purchased Shares pursuant to this Agreement. Each
Selling Shareholder further expressly acknowledges that any such Corporate Event may result in the payment by the Company of assets,
funds or other proceeds to the Company’s shareholders or an enhancement in value of the Company’s securities, including in
a manner such that the value that would have been attributable to the Purchased Shares in such Corporate Event in the absence of this
Agreement (either in an aggregate amount or on a per share basis) would be greater than the value attributed to the Purchased Shares
hereunder. Each Selling Shareholder hereby acknowledges and agrees that after the sale of the Purchased Shares at the Closing, under
the foregoing circumstances or upon any such Corporate Event, such Selling Shareholder shall have no right to or interest in any such
assets, funds, proceeds or enhanced value by reason of such Selling Shareholder’s ownership of the Purchased Shares.

 

Section
9.4 Release Upon Closing. Effective from and after the Closing, each Selling Shareholder, for itself, himself or herself, as applicable,
and on behalf of their respective successors and assigns, irrevocably and unconditionally waives, releases and promises never to assert
any claims, causes of action or similar rights of any type that such Selling Shareholder or any such Selling Shareholder’s successors
or assigns may currently have, whether or not now known against the Purchaser, the Company, its subsidiaries, their respective Affiliates
or their or any such Affiliate’s respective current or former managers, equity holders, officers, agents or employees (collectively,
the “Released Parties”) which relate to the Company and/or its subsidiaries and are on account of any matter attributable
to the period, or arising during the period, from the beginning of time through and including the Closing Date, with the exception of
Specified Obligations (the “Released Claims”). Each Selling Shareholder acknowledges and agrees that (a)
the release contained in this Section 9.4 (this “Release”) shall be effective as a bar to all Released Claims; and (b) this
Release shall be given full force and effect according to each and all of its express terms and provisions. “Specified Obligations”
means (a) the respective rights of each party as set forth in this Agreement or any of the Transaction Documents to which such party
is a party; and (b) the rights of any Selling Shareholder may have that relate to any commercial, employment or indemnification agreements
between such Selling Shareholder (and/or its Affiliates, partners, managers or employees) and the Company or any subsidiary, which shall
survive in accordance with their terms. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE REQUIREMENTS OF LAW, EACH SELLING SHAREHOLDER,
FOR SUCH SELLING SHAREHOLDER AND SUCH SELLING SHAREHOLDER’S SUCCESSORS AND ASSIGNS, WAIVES THE BENEFIT OF ANY PROVISION OF APPLICABLE
LAW TO THE EFFECT THAT A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS OR MATTERS WHICH THE SELLING SHAREHOLDER DID NOT KNOW OR SUSPECT TO
EXIST IN THE SELLING SHAREHOLDER’S FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY THE SELLING SHAREHOLDER MAY HAVE
AFFECTED ITS SETTLEMENT WITH ANY RELEASED PARTY. The provisions of this Section 9.4 were specifically bargained for among the parties
and were taken into account by the parties in arriving at the consideration paid pursuant to this Agreement and its decision to enter
into the transactions contemplated hereby. The Purchaser has specifically relied upon the provisions of this Section 9.4 in agreeing
to the consideration paid pursuant to this Agreement and its decision to enter into the transactions contemplated hereby.

 

    	37

    	 

    

 

Section
9.5 Release of Claims by Terminated Option Holders. Neither the Company nor the Purchaser shall be obligated to make any payment
to a holder of a Terminated Option in respect of such holder’s applicable portion of the Closing Options Payout Amount, unless
and until such holder delivers to each of the Company and the Purchaser a form of release and termination reasonably acceptable to the
Company and the Purchaser and duly executed by such holder, provided that such form shall include surrender of such Terminated Options
and termination of any prior option grant agreements or other agreements or arrangements promising the grant of such options, and release
of any claims substantially similar to that provided by the Selling Shareholders in Section 9.3. Each holder of a Terminated Option shall
execute this Agreement or a joinder agreeing to become a party to this Agreement.

 

The
parties acknowledge and agree that notwithstanding the agreements and undertakings of the Company hereunder with respect to the Terminated
Options, nothing contained in this Agreement shall constitute an admission or acknowledgement by the parties that the provisions of this
Agreement require the making of any payments to the holder of any Terminated Option (including, without limitation, the Closing Options
Payout Amount), and the provisions of this Agreement providing for the payment of any amounts to the holders of any Terminated Option
(including, without limitation, the Closing Options Payout Amount) shall not inure to the benefit of the holders of any Terminated Option,
their respective successors or assigns, or any other Person not a party to this Agreement.

 

Section
9.6 Indemnification Against Claims by Terminated Option Holders. Subject to the terms, conditions and limitations set forth in
this Article IX, the Terminated Option Holders shall (severally and not jointly) without any right of contribution from the Company,
indemnify, defend and hold harmless each of the Purchaser Indemnified Parties, from and against, and shall promptly pay or reimburse
each Purchaser Indemnified Party for, any and all Losses sustained or incurred by any Purchaser Indemnified Party in connection with
the cancellation of the Terminated Options or the payment of the Closing Options Payout Amount, each as set forth in Section 2.1(c),
or any other matters relating to or arising in connection with the Terminated Options.

 

ARTICLE
X

SURVIVAL;
LIMITATIONS ON LIABILITIES

 

Section
10.1 Survival.

 

(a)
The representations and warranties regarding the Company in Article V shall survive the Closing and for eighteen (18) months following
the Closing, save that for representations and warranties under (x) Section 5.1 (Existence and Power) to Section 5.5 (No Legal Bar) (but
other than clauses (c) and (d) of Section 5.2) and Section 5.15 (Capitalization) shall survive the Closing for five (5) years and (y)
Section 5.10 (Taxes) and Section 5.13 (Environmental Matters) shall survive the Closing for an additional one (1) year following the
expiry of the relevant statutory limitation periods.

 

    	38

    	 

    

 

(b)
The representations and warranties of the Selling Shareholders in Article VI shall survive the Closing for eighteen (18) months following
the Closing, provided that Section 6.2 (Ownership) shall survive the Closing for five (5) years.

 

(c)
The covenants and agreements that by their terms are to be performed following the Closing pursuant to this Agreement shall survive the
Closing in accordance with their terms and all other covenants and agreements herein shall terminate and shall not survive the Closing.

 

(d)
Notwithstanding anything to the contrary set forth in this Section 10.1, in no event will the provisions of this Section 10.1 have the
effect of reducing or limiting any statute of limitations for any claims based on Fraud.

 

(e)
Notwithstanding anything to the contrary set forth in Section 10.1, if, at any time prior to the applicable termination date set forth
in Section 10.1(a) through (c) above, the Purchaser (acting in good faith), as the case may be, delivers to the Company or Selling Shareholders
(in either case, relating to indemnification pursuant to Section 10.2), respectively, a written notice asserting a claim for recovery
under Section 10.2, then the claim asserted in such notice shall survive the expiration of the applicable survival period set forth Section
10.1(a) through (d) above and, in the case of a claim for Fraud, the expiration of the applicable statute of limitations time period,
if longer than such survival period, until such time as such claim is fully and finally resolved and, Losses arising therefrom have been
fully recovered. Such notice shall be prompt and shall set forth in reasonable detail such claim and the basis for indemnification, provided,
however, that any failure to give such notification on a timely basis or to provide any particular details therein shall not relieve
the Selling Shareholders of its obligation to indemnify the Purchaser Indemnified Parties hereunder except to the extent that such failure
to provide, delay in providing or omission of any particular detail actually and materially prejudices the ability of the Selling Shareholders
to defend against such matter. Each claim notice shall be accompanied by copies of any material documentation relevant to such claim
and shall describe in reasonable detail (to the extent known) the facts constituting the basis for such claim and the amount (if known)
of the claimed Losses.

 

Section
10.2 Indemnification by Selling Shareholders. Subject to the terms, conditions and limitations set forth in this Article X,
the Selling Shareholders shall (severally and not jointly, based upon each Selling Shareholder’s Pro Rata Share (as defined below)),
without any right of contribution from the Company, indemnify, defend and hold harmless each of the Purchaser Indemnified Parties, from
and against, and shall promptly pay or reimburse each Purchaser Indemnified Party for, any and all Losses (including, if applicable,
any Losses that Purchaser continues to sustain or incur after the end of the applicable survival period in connection with a claim that
is made prior to the end of the applicable survival period in accordance with the terms of this Agreement) sustained or incurred by any
Purchaser Indemnified Party resulting from (i) any misrepresentation or breach of any representation and warranties regarding the Company
in Article V, (ii) any breach or non-fulfillment of any covenant or agreement made or to be performed by the Company in this Agreement
or any certificate delivered in connection with this Agreement (together with clause (i), “Company Breaches”). In the event
of any Losses resulting from the Company Breaches, the Purchaser shall first satisfy all such Losses from each Founding Shareholder (subject
to Section 10.3(b)) up to such an aggregate amount equal to five percent (5%) of the Purchase Price, provided that in the case of Fraud
with respect to any of the representations and warranties of the Company in Article V, up to one hundred percent (100%) of the applicable
portion of the Purchase Price received by such Founding Shareholder (the “Founder Initial Indemnity Cap”). In the event that
the Losses resulting from the Company Breaches exceed the Founder Initial Indemnity Cap, following exhaustion of the Founder Initial
Indemnity Cap, the Purchaser shall then be permitted to satisfy the Losses from each Selling Shareholder (including each Founding Shareholder
in his or her capacity as a Selling Shareholder) (subject to Section 10.3(b)) up to such Selling Shareholder’s portion of an amount
equal to five percent (5%) of the Purchase Price prorated among such Selling Shareholders based on the number of the Purchased Shares
sold by each such Selling Shareholder as a fraction of the total Purchased Shares (such shares, as set forth on Exhibit 1, each Selling
Shareholder’s “Pro Rata Share”) (the “Seller Initial Indemnity Cap”). In the event that the Losses resulting
from the Company Breaches exceed the Seller Initial Indemnity Cap, following exhaustion of the Seller Initial Indemnity Cap, the Purchaser
shall be entitled to recourse against the Company subject to Section 10.3(a) below.

 

    	39

    	 

    

 

 

Further,
each Selling Shareholder shall indemnify, defend and hold harmless each of the Purchaser Indemnified Parties, from and against, and shall
promptly pay or reimburse each Purchaser Indemnified Party for, any and all Losses sustained or incurred by any Purchaser Indemnified
Party resulting from (i) any misrepresentation or breach of any of the representations and warranties of such Selling Shareholder in
Article VI, or (ii) any breach or non-fulfillment of any covenant specifically required to be performed by such Selling Shareholder in
this Agreement or any certificate delivered in connection with this Agreement (together with clause (i), “Selling Shareholder Breaches”).

 

Section
10.3 Limitations on Liabilities.

 

(a)
Subject to Section 10.2, except in the case of Fraud with respect to the representations in Article V, the Company shall not be liable
to the Purchaser Indemnified Parties for any Losses resulting from the Company Breaches in excess of the Signing Payment and, if received
by the Company and the Additional Interim Payment, in each case to the extent actually received by the Company. In no event shall the
Company be liable for any Losses resulting from the Selling Shareholder Breaches. No Purchaser Indemnified Party shall be entitled to
recover any Losses for Company Breaches unless and until the aggregate Losses for which they would otherwise be entitled to indemnification
exceed Two Hundred Fifty Thousand Dollars ($250,000) at which point the Purchaser Indemnified Party shall become entitled to be indemnified,
compensated and reimbursed for all such Losses, subject to the terms and conditions set forth herein.

 

(b)
Except in the case of Fraud with respect to each such Selling Shareholder’s representations in Article VI, each Selling Shareholder
shall not be liable to any Purchaser Indemnified Party for any Losses resulting from such Selling Shareholder’s Selling Shareholder
Breaches for more than one hundred percent (100%) of the applicable portion of the Purchase Price received by such Selling Shareholder.
For the avoidance of doubt, no Selling Shareholder shall be liable for any Selling Shareholder Breaches of any other Selling Shareholder.
Notwithstanding anything to the contrary herein, (i) in no event shall the aggregate liabilities of each Selling Shareholder under this
Agreement exceed the applicable portion of the Purchase Price received by such Selling Shareholder, and (ii) in no event shall the aggregate
liability of each of the Founding Shareholders under this Agreement for any Company Breaches exceed their respective pro rata share of
the Founder Initial Indemnity Cap together with their Pro Rata Share of the Seller Initial Indemnity Cap, and in no event shall the aggregate
liability of each Selling Shareholder (other than the Founding Shareholders) under this Agreement for any Company Breaches exceed its
Pro Rata Share of the Seller Initial Indemnity Cap.

 

(c)
The indemnification provisions in this Article X shall be the sole and exclusive remedy of the Purchaser Indemnified Persons against
any Selling Shareholder, the Company, their respective Affiliates and their respective former, current and future shareholders, directors,
officers, employees and other representatives, for any claims for any monetary damages arising out of this Agreement or any certificate
or instrument delivered in connection with this Agreement, whether in contract, tort or otherwise. Notwithstanding the foregoing provisions
of this Section 10.3, in no event will Section 10.3 be deemed a waiver by any party of any right to specific performance or injunctive
or equitable relief, any right or remedy arising from a criminal act, or any right or remedy arising by reason of any claim of Fraud.

 

    	40

    	 

    

 

(d)
No Purchaser Indemnified Party shall be entitled to any duplicative recovery for any Losses, and any Losses for indemnification under
this Agreement shall be determined without duplication of recovery due to the facts giving rise to such Losses constituting a breach
of more than one representation, warranty, covenant or agreement.

 

Section
10.4 Rights of Purchaser. Notwithstanding any other provision of this Agreement or the Transaction Documents, the rights of the
Purchaser to indemnification or any other remedy under this Agreement shall not be impacted or limited by any knowledge that the Purchaser
may have acquired, or could have acquired, whether before or after the date of Closing, nor by any investigation or diligence by the
Purchaser, except for the matters disclosed in the Disclosure Schedule or actual knowledge of the Purchaser prior to the date hereof.
The Company and each of the Selling Shareholders hereby acknowledge that, regardless of any investigation made (or not made) by or on
behalf of the Purchaser, and regardless of the results of any such investigation, the Purchaser has entered into this transaction in
express reliance upon the representations and warranties of the Company and the Selling Shareholders made in this Agreement. The Purchaser
hereby acknowledges and agrees (for itself and on behalf of any other Purchaser Indemnified Persons) that (1) the representations and
warranties of the Company and the Selling Shareholders expressly set forth in Article V and Article VI constitute the sole and exclusive
representations and warranties of the Company and the Selling Shareholders or any of their respective businesses, prospects or operations
or otherwise in connection with this Agreement, and (2) except for the subject matter covered in Article V and Article VI, neither the
Company, the Selling Shareholders, nor any current or former shareholder (other than Selling Shareholders as a shareholders of the Company
pursuant hereto), director, officer, employee, Affiliate or other representative of the Company or the Selling Shareholders has made
and is not making, and the Purchaser is not relying upon, any representations or warranties whatsoever regarding Selling Shareholders
or the Company or the subject matter of this Agreement, express or implied. During the Restricted Period, the Company will continue to
accommodate Purchaser’s reasonable requests to conduct further diligence and timely respond to Purchaser’s reasonable inquiries
and requests for additional documents with respect to the Company and its Subsidiaries in connection with the Transaction.

 

Section
10.5 Delivery of Shares. In the case of the Founding Shareholders and any other Selling Shareholder who will continue to hold
Shares immediately after the Closing, such Selling Shareholder shall have the right to deliver and assign to the Purchaser the Shares
held by such Selling Shareholder in lieu of cash payment for any indemnification obligations hereunder, with such number of Shares being
determined by dividing (i) the amount of the indemnification obligation of such Selling Shareholder pursuant hereto by (ii)
the Per Share Purchase Price. To secure such obligation, the Founding Shareholders and any other Selling Shareholder who will continue
to hold Shares immediately after the Closing shall execute and deliver on or prior to the Closing a pledge agreement in favor of the
Purchaser for a number of Shares equal to the Founder Initial Indemnity Cap or such Selling Shareholder’s Pro Rata Share of the
Seller Initial Indemnity Cap, as applicable, in each case divided by the Per Share Purchase Price (and rounded to the nearest whole share).

 

    	41

    	 

    

 

ARTICLE
XI TERMINATION

 

Section
11.1 Termination. This Agreement may be terminated and the Transaction may be abandoned at any time prior to the Closing,

 

(a)
by mutual written agreement of the parties hereto;

 

(b)
by either the Company or the Purchaser, if the Closing shall not have occurred on or prior to the Long Stop Date;

 

(c)
by either the Company or the Purchaser, if any Applicable Law shall have been promulgated, entered, enforced, enacted or issued or shall
be deemed to be applicable to the Transaction by any Governmental Authority of competent jurisdiction which permanently prohibits, restrains
or makes illegal the consummation of the Transaction, provided, that the right to terminate this Agreement pursuant to this Section 11.1(c)
shall not be available to either party whose action or failure to perform any of its obligations under this Agreement is the primary
cause of, or primarily resulted in, the enactment or issuance of any such Applicable Law; and

 

(d)
by the Company in the event the Purchaser fails to make the Signing Payment or the Additional Interim Payment as contemplated by Section
2.3 hereof on or prior to the dates specified therein or fails to make the Extension Payment prior to the date that is sixty (60) days
from the date hereof.

 

Section
11.2 Effect of Termination. In the event of termination of this Agreement pursuant to Section 11.1, this Agreement shall forthwith
become null and void and have no effect, without any liability on the part of any party hereto; provided, however, that no such termination
shall relieve any party of any liability or damages resulting from fraud; provided, further, that this Section 11.2, Section 11.3 and
Article XII hereof shall survive any termination of this Agreement.

 

Section
11.3 Expenses. All fees and expenses incurred by the parties shall be borne solely by the party that has incurred such fees and
expenses including, for the avoidance of doubt, the stamp duty amount which shall be payable by the Purchaser.

 

ARTICLE
XII

MISCELLANEOUS

 

Section
12.1 Entire Agreement. This Agreement, together with the exhibits and schedules hereto, contain the entire understanding of the
parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, including, without limitation the Letter of Intent between the Company and Purchaser, dated January 15, 2021, which
the parties acknowledge have been merged into such documents, exhibits and schedules.

 

Section
12.2 Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, by all signatories. No waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement thereof, nor shall any delay or omission of any party to exercise any right thereunder in any manner impair the exercise
of any such right.

 

Section
12.3 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of the Purchaser (other than by merger). Following the Closing, any Purchaser may assign, on ten (10) Business Day prior notice any or
all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Purchased Shares, provided that
such transferee agrees in writing to be bound with respect to the transferred Purchased Shares by the provisions of the Transaction Documents
that apply to the “Purchaser” and is able to make each and every representation made by Purchaser in this Agreement. No assignment
by a Purchaser will be allowed if the result would be an increase in the number of actual or beneficial owners of the assigned Purchased
Shares.

 

    	42

    	 

    

 

Section
12.4 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the laws of Singapore, without giving effect to the conflict of laws
provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other
than those of the laws of Singapore.

 

Section
12.5 Arbitration. Any dispute arising out of or in connection with this Agreement, including any question regarding its existence,
validity or termination, shall be referred to and finally resolved by arbitration administered by the Singapore International Arbitration
Centre (“SIAC”) in accordance with the Arbitration Rules of the Singapore International Arbitration Centre (“SIAC Rules”)
for the time being in force, which rules are deemed to be incorporated by reference in this Section 12.5. The seat of the arbitration
shall be Singapore. The Tribunal shall consist of three (3) arbitrators comprising one arbitrator appointed by the Company, one appointed
by the Purchaser and one arbitrator appointed by the President of the Court of Arbitration for the time being of the SIAC in each case
such arbitrator shall be qualified to practice law in Singapore. The language of the arbitration shall be English. The place of arbitration
hearings shall be in Singapore. The parties hereto further agree that following the commencement of arbitration, they will attempt in
good faith to resolve the dispute through mediation at the Singapore International Mediation Centre (“SIMC”), in accordance
with the SIAC-SIMC Arb-Med- Arb Protocol for the time being in force. Any settlement reached in the course of the mediation shall be
referred to the arbitral tribunal appointed by SIAC and may be made a consent award on agreed terms. Notwithstanding anything in this
Agreement, the parties hereto acknowledge and agree that the parties shall, to the extent permitted by the SIAC Rules, have the right
at any time to apply to the arbitrator for interim injunctive relief in relation to any dispute arising out of or in connection with
this Agreement.

 

Section
12.6 Severability. If any term, provision, covenant or restriction of any Transaction Document is held by a court of competent
jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth
herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as
that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties
that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter
declared invalid, illegal, void or unenforceable.

 

Section
12.7 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

Section
12.8 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and the Purchased Shares in any Transaction Document shall be subject to adjustment for share
splits, share dividends, share consolidation and other similar transactions of the Purchased Shares that occur after the date of this
Agreement. References to $, US$ or USD in this Agreement are references to the lawful currency from time to time of the United States
of America.

 

    	43

    	 

    

 

Section
12.9 Execution. This Agreement may be executed in any number of counterparts and by the several parties on separate counterparts
each of which when so executed shall be an original but all counterparts shall together constitute one and the same instrument.

 

Section
12.10 Payments. Evidence of any wire transfer, and compliance with any obligation to pay any amount under this Agreement shall
take the form of a MT103 advice, federal reference number of a wire transfer, or written confirmation from the paying bank that it has
made such payment (in the form of a screen shot of such paying bank’s wiring record) and receipt of such monies payable shall be
deemed to occur on the provision of such advice or written confirmation.

 

Section
12.11 Waiver of Conflicts. Each party to this Agreement acknowledges that Cooley LLP (“Cooley”) has acted as counsel
solely to the Company with respect to this Agreement and the Transaction contemplated hereby, and has negotiated the terms of the Transaction
solely on behalf of the Company. Cooley may have, in the past, represented and/or may, now or in the future, represent one or more other
parties to this Agreement and/or their Affiliates in other matters, including matters that are similar, but not substantially related,
to the Transaction. The applicable rules of professional conduct require that Cooley inform its clients of these representations and
obtain their waivers of the conflicts that may arise from such representations. The Company and each other party to this Agreement hereby
(a) acknowledges that such party has been advised about such circumstances and has had an opportunity to ask for additional information,
(b) acknowledges that, with respect to the Transaction, Cooley has represented solely the Company and no other party, and (c) gives its
informed consent to Cooley’s representation of the Company in the Transaction and Cooley’s representation of other parties
to this Agreement and/or their Affiliates in other matters.

 

Section
12.12 Notices.

 

(a)
Unless otherwise provided herein, all notices, requests, waivers and other communications (“Notices”) shall be made in English,
in writing and by letter (delivered personally, by courier or by mail or air mail) or by electronic mail (save as otherwise stated) and
shall be deemed to be duly given or made upon the earlier of actual receipt or:

 

(i)
in the case of personal, when delivered;

 

(ii)
in the case of courier delivery, one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid,
specifying next Business Day delivery, with written verification of receipt;

 

(iii)
in the case of mail (which shall be used only for domestic delivery), except air mail, five (5) days after having been sent by registered
or certified mail, return receipt requested, postage prepaid;

 

(iv)
in the case of air mail, six (6) Business Days after posting; or

 

(v)
in the case of electronic mail (A) during normal business hours of the recipient, at the time of transmission and (B) if not sent during
normal business hours, then on the recipient’s next Business Day.

 

    	44

    	 

    

 

(b)
If any Notice is delivered by means other than electronic mail, a copy of such Notice shall be sent by electronic mail promptly after
such Notice is sent by such other means, but no later than one (1) Business Day thereafter.

 

(c)
If delivery or receipt occurs on a day other than a Business Day, or is later than 5 p.m. (local time) on a Business Day, it will be
taken to have been duly delivered and received at the commencement of the next Business Day.

 

(d)
The address for Notices for the parties hereto shall be as set forth in Exhibit 3 of this Agreement. Such address may be changed by Notice
by any relevant party.

 

Section
12.13 Third Party Rights. A person who is not party to this Agreement will have no right under the Contracts (Rights of Third
Parties) Act (Cap. 53B) of Singapore to enforce any term of this Agreement. This clause does not affect any right or remedy of any person
which exists or is available otherwise than pursuant to that Act.

 

Section
12.14 Sellers’ Representative. Each Selling Shareholder hereby irrevocably appoints Mr. Zhiwen as the sole representative
of each such Selling Shareholder (“Sellers’ Representative”) to act as the agent and on behalf of such Selling Shareholder
explicitly for the purpose of taking any and all actions that may be necessary or desirable, as determined by the Sellers’ Representative,
in its sole discretion, in connection with paying, negotiating, or entering into settlements and compromises of any claim for indemnification
pursuant to Article X hereof. Purchaser may conclusively rely upon, without independent verification or investigation, all decisions
made by and actions taken by the Sellers’ Representative in connection with this Agreement. If Mr. Zhiwen becomes unable to serve
as the Sellers’ Representative, such other Person or Persons as may be designated by the Selling Shareholders who held a majority
of the Purchased Shares prior to the Closing shall succeed as the Sellers’ Representative. The Sellers’ Representative shall
not be liable to the Selling Shareholder for any action taken or omitted by it as permitted under this Agreement, except for bad faith
or willful misconduct. The Sellers’ Representative will also be fully protected in relying upon any written notice, demand, certificate
or other document that it in good faith believes to be genuine (including electronic copies thereof). Each Selling Shareholder agrees,
severally but not jointly, to indemnify the Sellers’ Representative for, and to hold the Sellers’ Representative harmless
against, any loss, liability or expense incurred without willful misconduct or bad faith on the part of the Sellers’ Representative,
arising out of or in connection with the Sellers’ Representative’s carrying out its duties under this Agreement, including
costs and expenses of successfully defending the Sellers’ Representative against any claim of liability with respect thereto. The
Sellers’ Representative may consult with counsel of its own choice, at no expense to Purchaser or the Company, and will have full
and complete authorization and protection for any action taken and suffered by it in good faith.

 

(Signature
Pages Follow)

 

    	45

    	 

    

 

IN
WITNESS WHEREOF , the parties hereto have caused this Securities Purchase Agreement to be duly executed and delivered as a deed by their
respective authorized signatories as of the date first indicated above.

 

	 	Executed
    and delivered as a Deed by
	 	Company:
	 	 	 
	 	LOMOTIF
    PRIVATE LIMITED
	 	 
	 	

By:

	
	 	 	 
	 	Name:	Paul Yang Zhiwen
    
	 	 	 
	 	Title:	Chief
    Executiv e Officer

 

		Witnessed by:

 

[Signature
Page to the Securities Purchase Agreement]

 

    	 

    	 

    

 

	 	Executed
    and delivered as a Deed by Purchaser:
	 	By:	

	 	 	 
	 	Name:
    	Ted
    Farnsworth
	 	 	 
	 	Title:	CEO/Founder
	 	 	 
	 	Witnessed by:

 

[Signature
Page to the Securities Purchase Agreement]

 

    	 

    	 

    

 

	 	Executed and delivered as a Deed by
	 	Selling Shareholder:
	 	 
	 	 
	 	 
	 	Witnessed
  by:

 

[Signature
Page to the Securities Purchase Agreement]

 

    	 

    	 

    

 

EXHIIBIT
1

 

Purchased
Shares

 

    	 

    	 

    

 

EXHIBIT
2

 

TERMS
OF THE A&R SHAREHOLDERS AGREEMENT

 

	Right
    of First Refusal	 	In
    the event that any shareholder of the Company decides to sell, transfer or exchange, directly or indirectly, their equity securities,
    Zash shall have a right of first refusal to purchase all or any portion of the equity securities that such shareholder may propose
    to transfer, at the same price and on the same terms and conditions as those offered to the prospective purchaser of the equity securities.
	 	 	 
	Tag
    Along Right	 	None
    of the shareholders of the Company may sell, transfer or exchange, directly or indirectly, their equity securities unless each other
    non-selling shareholder has an opportunity to participate in the sale on a pro-rata basis on the same terms and conditions and for
    the same consideration as the selling shareholder.
	 	 	 
	Drag
    Along Right	 	In
    the event that Zash decides to sell, transfer or exchange, directly or directly, its equity securities as a result of which no less
    than 50% of the outstanding shares of the Company will be transferred, Zash shall have the opportunity to “drag along”
    other shareholders to participate in the sale on a pro-rata basis on the same terms and conditions and for the same consideration
    as Zash.
	 	 	 
	Management

                                                         Authority
	 	The
    Founder shall be the Chief Executive Officer of the Company and shall have responsibility and authority over all day-to-day business
    decisions, the granting of stock options to the Company team (within the limitations of the ESOP pool), hiring and firing of employees,
    and other responsibilities typically associated with the role of Chief executive Officer. Zash will not be involved in the day-to-day
    operations of the Company.

 

    	 

    	 

    

 

EXHIBIT
3

 

NOTICE

 

    	 

    	 

    

 

EXHIBIT
4

 

Form
of the Convertible Note Subscription Agreement

 

See
attachedExhibit
10.2

 

EXECUTION
VERSION

 

THIS
DEED OF VARIATION AND SUPPLEMENT (this “Deed”) is made this 19th day of July 2021 by and among Lomotif
Private Limited (UEN: 201406142D), a private company limited by shares incorporated in Singapore (the “Company”),
Zash Global Media and Entertainment Corp., a Delaware Corporation (the “Initial Purchaser”), ZVV MEDIA PARTNERS, LLC,
a limited liability company incorporated and registered in the State of Delaware with company registration number 5957339 (the “Purchaser
Assignee”) and those persons whose names are set forth on the signature pages hereto as Sellers (the “Sellers”),
to vary and supplement the terms of the Securities Purchase Agreement, dated as of February 23, 2021, by and among the Company, the Initial
Purchaser and the Sellers (the “SPA”).

 

The
Company, the Initial Purchaser, the Purchaser Assignee and the Sellers are hereinafter called, collectively, the “Parties”
or each a “Party”. Capitalised terms used but not otherwise defined herein shall have the meanings ascribed to them
in the SPA.

 

Background

 

	(A)	On
                                            or about the date of this Deed:

 

		(I)	the
                                            Initial Purchaser intends to novate its rights and obligations under the SPA to the Purchaser
                                            Assignee;

 

		(II)	the
                                            holders of the Outstanding Convertible Notes intend to convert all of such Outstanding Convertible
                                            Notes into Ordinary Shares prior to Closing; and

 

		(III)	the
                                            Parties intends to amend certain other terms of the SPA to reflect the agreement of the Parties.

 

	(B)	In
                                            connection with the foregoing transactions, the Parties desire to vary and supplement the
                                            terms of the SPA in accordance with section 12.2 thereof and the following provisions of
                                            this Deed.

 

Operative
Provisions

 

	1.	Assignment

 

	1.1	Immediately
                                            prior to the occurrence of Closing and subject to all conditions to Closing having been satisfied
                                            or otherwise waived by the Purchaser (as the case may be) (the “Effective Date”),
                                            the Initial Purchaser will novate all of its rights and obligations under the SPA to the
                                            Purchaser Assignee and the Purchaser Assignee will assume all of the Initial Purchaser’s
                                            rights and obligations under the SPA and agrees to be bound by the provisions of the Transaction
                                            Documents that apply to the “Purchaser” with effect from the Effective Date.
                                            The Purchaser Assignee represents and warrants as of the date hereof and as of the Closing
                                            Date to the Company and each Seller that each and every representation made by the Purchaser
                                            in the SPA is true and correct as applied to the Purchaser Assignee. The parties hereto acknowledge
                                            and agree that:

 

    	 

    	 

    

 

		(a)	The
                                            Initial Purchaser shall as from the Effective Date transfer and novate all its rights and
                                            obligations under the SPA to the Purchaser Assignee. The Purchaser Assignee shall as from
                                            the Effective Date enjoy all the rights and benefits of the Initial Purchaser under the SPA,
                                            as if the Initial Purchaser had been a party to the SPA in place of the Initial Purchaser,
                                            and all references to the Initial Purchaser in the SPA shall be read and construed as references
                                            to the Purchaser Assignee;

 

		(b)	as
                                            from the Effective Date, the Purchaser Assignee shall perform the obligations under the SPA
                                            and be bound by the terms of the SPA in every way as if it were the original party to the
                                            SPA in place of the Initial Purchaser;

 

		(c)	the
                                            Company, the Selling Shareholders and the Initial Purchaser shall mutually release each other
                                            from all future claims and demands whatsoever in respect of the SPA on or after the Effective
                                            Date. The Company, the Selling Shareholders and the Purchaser Assignee shall mutually accept
                                            each other’s liability in respect of the SPA as from the Effective Date.

 

For
the avoidance of doubt, prior to the Effective Date, the Initial Purchaser shall have the rights and obligations of the “Purchaser”
under the SPA and remain bound by the terms of the SPA as the “Purchaser” under the SPA.

 

	2.	Variation
                                            and Supplement

 

	2.1	Convertible
                                            Note issued to Bergwood Ventures

 

		(a)	The
                                            Company incurred additional borrowing of US$10,000 from Bergwood Ventures Pte. Ltd. (and/or
                                            its nominees) (“Bergwood”) under the “Term Sheet Relating to the
                                            Subscription of Convertible Notes” dated 24 September 2020 (the “Bergwood
                                            Term Sheet” and such borrowing, the “Additional Borrowing”),
                                            which was inadvertently not included in the SPA or Disclosure Schedules. The Company hereby
                                            seeks to amend the SPA and the Disclosure Schedules with respect to Bergwood, the Bergwood
                                            Term Sheet and the Additional Borrowing.

 

		(b)	Bergwood
                                            will be issued 533 Ordinary Shares of the Company and agrees to dispose of such shares to
                                            the Purchaser as at Closing. Further, Bergwood agrees to be a party to the SPA by way of
                                            the execution of this Deed and Parties acknowledge and agree that the terms “Selling
                                            Shareholder” and “Outstanding Convertible Notes” in the SPA shall be deemed
                                            amended to include Bergwood and the Additional Borrowing respectively and Schedule 1.1(a)
                                            (Material Contracts) and the term “Funded Notes” in the Disclosure Schedules
                                            shall be deemed amended to include the Bergwood Term Sheet accordingly.

 

    	2

    	 

    

 

		(c)	Save
                                            as to the foregoing, the Company represents and warrants to the Purchaser that as at the
                                            date hereof and as of the Closing, none of the Unfunded Notes have been funded and as such,
                                            none of the holders of the Unfunded Notes has been granted, nor has it entered into any agreement
                                            arising out of or in relation to the Unfunded Notes to grant, any rights of whatever kind
                                            or nature to acquire additional shares of the Companies equity securities.

 

	2.2	Each
                                            holder of the Outstanding Convertible Notes hereby agrees that the entire amount owed by
                                            the Company to such Selling Shareholder under such Outstanding Convertible Note is being
                                            tendered to the Company in exchange for the applicable Conversion Shares set forth on Schedule
                                            1.1(b) to the SPA (as amended hereunder) and, effective upon the Closing, without any further
                                            action required by the Company or such holder, such Outstanding Convertible Note and all
                                            obligations set forth therein shall be immediately deemed satisfied in full and terminated
                                            in its entirety. The Parties agree and acknowledge that, upon Closing, the Note Repayment
                                            Amount shall be zero (0) dollars.

 

	2.3	Former
                                            Employees Rights to be allotted with shares of the Company

 

		(a)	Subsequent
                                            to the signing of the SPA and notwithstanding the covenant under section 8.1(a) of the SPA,
                                            the Company has agreed to issue and allot to Chua Rui Wen and Benjamin Chang (collectively,
                                            the “Former Employees”) 23,159 Ordinary Shares and 15,439 Ordinary Shares
                                            respectively (collectively, the “Former Employee Shares”) in full and
                                            final settlement of the dispute with these Former Employees in accordance with the terms
                                            of the respective Settlement Agreement and Share Awards Letter (collectively, the “Settlement
                                            Documentation”).

 

		(b)	Pursuant
                                            to the Settlement Documentation, the Company will be appointed as the attorney of the Former
                                            Employees and procure that the entirety of the Former Employee Shares be transferred to the
                                            Purchaser on the Closing.

 

		(c)	The
                                            Company represents and warrants for itself and in the capacity as an attorney of the Former
                                            Employees that: (i) the allotment of Former Employee Shares shall be a full and final settlement
                                            of any and all claims in relation to the Former Employees; and (ii) the Former Employee Shares
                                            as allotted will rank pari passu with the existing Ordinary Shares of the Company.

 

		(d)	The
                                            Former Employees hereby agree to: (i) assume the rights and obligations and (ii)
be bound by the terms and conditions of this Deed and the SPA as if they were a party to the SPA with effect from the date of this Deed
for the benefit of the Purchaser (which, for the purpose of this clause, includes both the Initial Purchaser and the Purchaser Assignee).
Accordingly, reference to “Selling Shareholders” in the SPA shall be deemed amended to include the Former Employees.

 

    	3

    	 

    

 

	2.4	In
                                            furtherance of Section 2.3 above, the Parties hereby agree and acknowledge that:

 

		(a)	the
                                            definition of the term “Aggregate Shareholder Consideration” is hereby replaced
                                            in its entirety with the following:

 

““Aggregate
Shareholder Consideration” means the Purchase Price minus the Former Employee Payout.”

 

		(b)	the
                                            definition of the term “Former Employee Payout” will be added immediately after
                                            the definition of the term “Founding Shareholders” as follows:

 

““Former
Employee Payout” means US$299,983.36 which shall be paid to Chua Rui Wen by the Purchaser in exchange for the acquisition of his
7,684 ordinary shares within 14 days following the Closing.”;

 

		(c)	the
                                            definition of the term “Shareholder Share Equivalents” is hereby replaced in
                                            its entirety with the following:

 

““Shareholder
Share Equivalents” means the shares or share equivalents equal to the Purchased Shares plus the number of Terminated Options
(if not already included in the Purchased Share) plus the number of Shares issued or issuable pursuant to any warrants issued
by the Company (including the UMG Warrant) or Outstanding Convertible Notes in each case that are being converted and/or exercised (for
cash or on a net-exercise) in connection with the Closing (if not already included in the Purchased Shares) plus 15,475 ordinary
shares issuable to Chua Rui Wen plus 15,439 ordinary shares issuable to Benjamin Chang.”.

 

	2.5	Terminated
                                            Options in relation to Employees and Advisors of the Company

 

		(a)	The
                                            definition of the term “Terminated Options” is hereby replaced in its entirety
                                            with the following:

 

““Terminated
Options” means up to 201,972 options of the Company issued and outstanding (or deemed issued and outstanding) immediately prior
to Closing, of which allocation details are set forth under the column “Terminated Options” in Schedule 1.1(d).”

 

    	4

    	 

    

 

		(b)	The
                                            Parties hereby agree and acknowledge that, notwithstanding anything to the contrary in the
                                            SPA, subject to the written consent of a holder of the applicable Terminated Options, all
                                            of such holder’s Terminated Options will be deemed to have been exercised at Closing
                                            and the Ordinary Shares issued to such holder will be sold to the Purchaser as Purchased
                                            Shares in accordance with the SPA. Upon such exercise of any Terminated Options and the sale
                                            of the Ordinary Shares issued in connection to the Purchaser therewith, the Purchaser shall
                                            pay to the Company all cash amounts in respect thereof by wire transfer of immediately available
                                            funds to the account designated by the Company. Promptly after receipt of such funds, the
                                            Company shall pay such funds to the respective holder pursuant to the Company’s standard
                                            payroll procedures on the Closing Date, provided that the Company shall be entitled to deduct
                                            any amount required to be withheld or deducted under Applicable Laws, including pursuant
                                            to Section 2.7 of the SPA.

 

		(c)	The
                                            Selling Employee Shareholders (defined below) hereby agree to: (i) assume the rights and
                                            obligations and (ii) be bound by the terms and conditions of this Deed and the SPA as if
                                            they were a party to the SPA with effect from the date of this Deed for the benefit of the
                                            Purchaser (which, for the purpose of this clause, includes both the Initial Purchaser and
                                            the Purchaser Assignee). Accordingly, reference to “Selling Shareholders” in
                                            the SPA shall be deemed amended to include the Selling Employee Shareholders.

 

	2.6	In
                                            furtherance of Sections 2.3 and 2.5(b), each Selling Shareholder hereby irrevocably and unconditionally
                                            (i) consents to the completion of (x) the issuance of Ordinary Shares to the holders of the
                                            Terminated Options (the “Selling Employee Shareholders”) upon exercise
                                            of the Terminated Options immediately prior to Closing, for US$0.02 per share, (y) the issuance
                                            of Ordinary Shares to each Former Employee within 14 days following the Closing in the amount
                                            set forth in Schedule I opposite such Former Employee’s name under the column
                                            “Former Employee Shares”, for US$0.02 per share and (z) the issuance of Ordinary
                                            Shares upon exercise of the UMG Warrant, and (ii) waives any anti-dilution right, preemptive
                                            right, right of first refusal, co-sale right, transfer restrictions, protective rights or
                                            other similar rights with respect to the issuance and transfer of such Ordinary Shares and
                                            waives any applicable notice periods that it may be entitled to with respect to such transactions,
                                            whether such rights or notice periods are provided for under any contract to which such shareholder
                                            is a party or under the Constitution or the Shareholders Agreement.

 

	2.7	For
                                            the avoidance of doubt, the Purchaser shall not be required to pay additional consideration
                                            to the Former Employees nor the Selling Employee Shareholders, other than the amount as set
                                            forth in the SPA, which shall in no event exceed US$100 million. Accordingly, the amount
                                            of purchase price payable to the Former Employees and the Selling Shareholders shall be deducted
                                            from the said US$100 million.

 

	2.8	The
                                            Initial Purchaser and the Purchaser Assignee hereby agree that the Initial Purchaser or the
                                            Purchaser Assignee may pay US$0.02 per share to the Company on behalf of the relevant Selling
                                            Employee Shareholders and/or Former Employees for the issuance of such Ordinary Shares and
                                            deduct from the Per Share Purchase Price payable in respect of each such Ordinary Share (or
                                            from the Former Employee Payout (as defined in Section 2.4(b), as applicable) in the case
                                            the subscription price of such Ordinary Share paid by the Initial Purchaser or the Purchaser
                                            Assignee.

 

    	5

    	 

    

 

	2.9	Section
                                            3.1(n) of the SPA is hereby replaced in its entirety with the following:

 

“(n)
Establishment of Equity Incentive Plan. The Company shall have delivered to the Purchaser evidence of establishment of an equity
incentive plan for the allotment and issuance of up to 465,827 Ordinary Shares in the Company.”.

 

	2.10	The
                                            definition of the term “Long Stop Date” is hereby replaced in its entirety with
                                            the following:

 

““Long
Stop Date” means 150 days from the date of signing of the SPA, unless otherwise agreed between the Company and the Purchaser in
writing.”

 

	2.11	Section
                                            2.6(a)(viii) of the SPA is hereby replaced in its entirety with the following:

 

“(viii)
deliver to the Purchaser financial statements of the Company, prepared in accordance with United States generally accepted accounting
principles, consistently applied (“US GAAP”), for (A) the fiscal year 2019, (B) the fiscal year 2020, and (C) the fiscal
quarter ended March 31, 2021 (collectively, the “US GAAP Financial Statements”).”

 

	2.12	Section
                                            5.11 of the SPA is hereby amended by adding the following to the end of such section:

 

“The
US GAAP Financial Statements truly and fairly present, in all material respects, the financial position of the Company and its Subsidiaries,
as of the respective dates thereof, and the results of operations thereof, as of the respective dates or for the respective periods set
forth therein, and are in conformity with US GAAP, Requirements of Law, Applicable Law and the past historical practices of the Company.
Except as set forth on Section 5.11, as of the dates of the US GAAP Financial Statements, neither the Company nor any Subsidiary had
any obligation, Indebtedness or liability (whether accrued, absolute, contingent or otherwise, and whether due or to become due), which
was not reflected or reserved against in the balance sheets which are part of the US GAAP Financial Statements, except for those incurred
in the ordinary course of business and which are fully reflected on the books of account of the Company or its Subsidiaries.”

 

	2.13	Section
                                            11.3 is hereby replaced in its entirety with the following:

 

“Section
11.3 Expenses. All fees and expenses incurred by the parties shall be borne solely by the party that has incurred such fees and
expenses, provided that the Purchaser shall bear the stamp duty amount payable in connection with the transfer of the Shareholder Share
Equivalents pursuant to this Agreement and all of the fees and expenses incurred by the Company for the preparation of the audited financial
statements of the Company for the fiscal years 2019 and 2020 and the US GAAP Financial Statements.”

 

    	6

    	 

    

 

	2.14	Section
                                            2.2(a) is hereby replaced in its entirety with the following:

 

“At
the Closing, the Purchaser shall pay the applicable portion of the Purchase Price by wire transfer of immediately available funds to
each Selling Shareholder (or the Company on such Selling Shareholder’s behalf) in an amount equal to the amount set forth for such
Selling Shareholder in the Closing Payment Schedule and in accordance with the wire instructions set forth for such Selling Shareholder
(or the Company, as applicable) on Exhibit 5 attached hereto.”

 

	2.15	Exhibit
                                            1 (Purchased Shares) to the SPA is deleted in its entirety and replaced by Exhibit 1 attached
                                            hereto.

 

	2.16	Exhibit
                                            3 (Notice) to the SPA is deleted in its entirety and replaced by Exhibit 2 attached
                                            hereto.

 

	2.17	Schedule
                                            1.1(b) (Outstanding Convertible Notes) to the SPA is deleted in its entirety and replaced
                                            by Exhibit 3 attached hereto.

 

	2.18	Schedule
                                            1.1(d) (Terminated Options) to the SPA is deleted in its entirety and replaced by Exhibit
                                            4 attached hereto.

 

	2.19	Schedule
                                            5.15 (Capitalization) to the Disclosure Schedule is deleted in its entirety and replaced
                                            by Exhibit 5 attached hereto.

 

	2.20	Exhibit
                                            6 attached hereto is hereby added to the SPA as Exhibit 5 (Selling Shareholder Wire Details)
                                            thereto.

 

	3.	General

 

	3.1	The
                                            Parties hereby agree that, except as supplemented, varied and/or amended by this Deed, the
                                            terms of the SPA are confirmed and shall continue in full force and effect in all other respects.
                                            If and to the extent the provisions of this Deed conflict with or are inconsistent with the
                                            SPA, this Deed shall prevail.

 

	3.2	Sections
                                            12.2 to 12.10 and 12.13 of the SPA are incorporated mutatis mutandis herein by reference.

 

    	7

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Deed to be duly executed and delivered by their respective authorized signatories
as of the date first indicated above.

 

	 	Executed
    and delivered as a Deed by
	 	Company:
	 	 	 
	 	Lomotif
    Private Limited
	 	 	 
	 	By:	 
	 	Name:	Paul
    Yang Zhiwen
	 	Title:	Chief
    Executive Officer / Director
	 	 	 
	 	Witnessed
    by:
	 	 	 
	 	 
	 	Name:	 
	 	Address:	

 

 

[Signature
Page to the Deed of Variation to SPA]

 

    	 

    	 

    

 

	 	Executed
    and delivered as a Deed by
	 	Initial
    Purchaser:
	 	 	 
	 	ZASH
    GLOBAL MEDIA AND 
	 	ENTERTAINMENT
    COMPANY
	 	 	 
	 	By:
    	 
	 	Name:
    	Ted
    Farnsworth
	 	Title:
    	CEO
	 	 	 
	 	Witnessed
    by:
	 	 	 
	 	 
	 	Name:
    	 
	 	Address:
    	 

 

[Signature
Page to the Deed of Variation to SPA]

 

    	 

    	 

    

 

	 	Executed
    and delivered as a Deed by
	 	Purchaser
    Assignee:
	 	 	 
	 	ZVV
    MEDIA PARTNERS, LLC
	 	 	 
	 	By:
    	 
	 	Name:
    	Ted
    Farnsworth
	 	Title:
    	Partner
	 	 	 
	 	Witnessed
    by:
	 	 	 
	 	 
	 	Name:
    	 
	 	Address:
    	 

 

[Signature
Page to the Deed of Variation to SPA] 

 

    	 

    	 

    

 

Schedule
I

 

Former
Employee Shares

 

    	 

    	 

    

 

Exhibit
1

 

Exhibit
1 to the SPA

 

Purchased
Shares

 

    	 

    	 

    

 

Exhibit
2

 

Exhibit
3 to the SPA

 

Notice

 

    	 

    	 

    

 

Exhibit
3

 

Schedule
1.1(b) to the Disclosure Schedule

 

Outstanding
Convertible Notes

 

    	 

    	 

    

 

Exhibit
4

 

Schedule
1.1(d) to the SPA

 

Terminated
Options

 

    	 

    	 

    

 

Exhibit
5

 

Schedule
5.15 to the Disclosure Schedule

 

Capitalization

 

    	 

    	 

    

 

Exhibit
6

 

Exhibit
5 to the SPA

 

Selling
Shareholder Wire Details

 

[see
attached]

 

    	 

    	 

    

 

	8	TNF
    VENTURES	Frank
    Lee	frank.lee@tnfventures.com	 	 	+65
    93830241	Beneficiary
                                            Account Name: TNF VENTURES PTE. LTD. Beneficiary Account Number: 517 660437 001

     

     

    Bank
    Name: OVERSEA-CHINESE BANKING CORPORATION LIMITED Bank SWIFT Code: OCBCSGSG

    Bank
    Address: OCBC CENTRE, FLOOR 9, 65 CHULIA STREET, SINGAPORE 049513

     

     

    Bank
    Code: 7339

     

    Branch
    Code : 517 (OCBC Centre)

     

     

    Preferred
    Currency: SGD$

	10	Paul
    Yang	Paul
    Yang	paul@lomotif.com	-	-	Paul:
                                            +65 8222 6156

    Melissa
    Oh (DBS): +65 97387858
	Beneficiary
                                            Name: Yang Zhiwen Paul DBS Account Number: 120-733714-2 Name of Beneficiary Bank: DBS Bank

    Address
    of Beneficiary Bank: 12 Marina Boulevard, DBS Asia Central, Marina Bay Financial Centre Tower 3, Singapore 018982

    Country:
    Singapore

    SWIFT
    Address/ Code: DBSSSGSG Preferred Currency: USD

     

    Please
    also attention the remittance to Melissa Oh (+65 97387858)

	11	Loh
    Xiu Hui	Loh
    Xiu Hui	loh.xiu.hui@gmail.com	-	-	+65
    8748 1213	Beneficiary
                                            Account Name:Loh Xiu Hui Important note, due to format:

    First
    Name: Loh Last Name: Xiu Hui

     

    Beneficiary
    Account Number: 120-100249-7 Bank Name: DBS Bank

    Bank
    SWIFT Code: DBSSSGSG

    Bank
    Address: 12 Marina Boulevard, DBS Asia Central, Marina Bay Financial Centre Tower 3, Singapore 018982

    Bank
    Code: 7171

    DBS
    eMulti-Currency Autosave Account: 120-100249-7 Preferred Currency: USD

	12	Vividthree
    Holdings Ltd	Charles
    Yeo	charles@vividthree.com	Melvin
    Ng	melvinng@vividthree.com   	Melvin:
    +65 97828929	 

    Beneficiary
    Name: Vividthree Holdings Ltd Beneficiary Bank Name: United Overseas Bank Ltd Beneficiary Bank Account : 769 995 975 1

    Beneficiary
    Bank Address: 80 Raffles Place #29-03, UOB Plaza 1, Singapore 048624.

    Beneficiary
    Branch Name: UOB Main Bank Code: 7375

    SWIFT
    Code: UOVBSGSGXXX

     

    Preferred
    Currency: USD$

	13	FVC-LOMO
    Pte. Ltd.	Wong
    Sang Wuoh      	sw@farquhar-capital.com	 	 	Jason
Su:+65 9025 3656

                                                                                                                       Sang: +65 8133 2195                   
	Beneficiary
                                            : FVC-LOMO PTE. LTD. Account Number : 072-026629-3

    Bank
    Name : DBS Bank Ltd Singapore DBS SWIFT Code (BIC) : DBSSSGSG

     

    Agent
    Bank for USD Currency

    JPMorgan
    Chase Bank, N.A. : CHASUS33

     

    Applicable
    to both SGD & USD ACCOUNT

 

    	 

    	 

    

 

	14	Alaap Tatwawadi	Alaap Tatwawadi	alaap.t@gmail.com	 	 	+6590700890	
    Beneficiary Account Name: Alaap Tatwawadi Beneficiary
    Account Number: 6313035325 Bank Name: United Overseas Bank

    Bank SWIFT Code: UOVBSGSG

    Bank Address: 80 Raffles Place, 1 UOB Plaza, Singapore 048624 Bank Code:
    7375

    Preferred Currency: USD$

	15	Ashnil Dixit	Ashnil Dixit	ashnil.dixit@gmail.com	 	 	+65 92735551	
    Beneficiary Account

    Name: Ashnil Dixit

    Beneficiary Account

    Number: 0304236255

    Bank Name: Citibank NA

    Bank SWIFT Code: CITISGSGGCB

    Bank Address: 268 Orchard Road, #08-01,

    Singapore 238856

    Bank Code:

    7214 Preferred

    Currency: USD$

	16	Tuna Investments LLC	Steve Chen	tunafat@gmail.com	 	 	+1 (650) 906-0700	
    Bank Name: Citibank NA, New York

    Bank Address: 399 Park Ave, New York, NY 10022, USA SWIFTID: CITIUS33

    Account Number: 4060-7595

    Account Name: Charles Schwab Co. Inc. FFC Account Name: Tuna Investments
    LLC FFC Account Number: 4688-7045

	17	Bergwood Ventures Pte Ltd	Tobias Berger	tdberger7@gmail.com	 	 	+65 9753 8756	
    Beneficiary Account Name: Bergwood Ventures Pte. Ltd.
    Beneficiary Account Number: 0489081546

    Bank Name: DBS Bank

    Bank SWIFT Code: DBSSSGSG

    Bank Address: 12 Marina Boulevard, DBS Asia Central, Marina Bay Financial
    Centre Tower 3, Singapore 018982

    Bank Code: n/a

    Preferred Currency: USD$

	18	Universal Music Investments, Inc.	Amy Strack Jason Gallien	amy.strack@umusic.com Jason.Gallien@umusic.com	Vangie Flowers	Vangie.Flowers@umusic.com	
    Call Bank of America: +1 888-

    715-1000 ext. 57264

     

    Universal Music: Amy: +1 (949)

    697-7585
	
    Beneficiary Account Name: Universal Music Investments, Inc. Account Number:
    0910705014

    Routing Number ACH/EFT: 122000661 Routing Number DOM. WIRES: 026009593

    SWIFT Code INTL WIRES: BOFAUS3N (BOFAUS6S If incoming wire is in foreign
    currency

    Account Address: 21301 Burbank Blvd. Woodlands Hills, CA 91367 Attn: Susanna
    Pedraza

	19	Lomotif Pte Ltd	Adele Tan	adele@lomotif.com	 	 	Adele: +65 8809 6080	
    Lomotif SINGAPORE Bank account wiring details

     

    Beneficiary Account Name: Lomotif Private Limited Beneficiary Account Number:
    0866375011

    Bank Name: Citibank N.A., Singapore Branch Bank Swift Code: CITISGSG

    Bank Address: 8 Marina View #22-01, Asia Square Tower 1, Singapore 018960

    Bank Code: 7214

    Branch Code: 001

	20	Chua Rui Wen	 	rwchua@gmail.com	 	 	+65 9456 7067 (please email)	
    Account Name: Chua Rui Wen Bank Name: DBS

    Account Number: 120-037274-7 Swift Code: DBSSSGSG

    Bank Address: 12 Marina Boulevard, DBS Asia Central, Marina Bay Financial

    Centre Tower 3, Singapore 018982

	21	Benjamin Chang	 	benchang@gmail.com	 	 	+1 424-242-2435	
    Account Number:4984061209 Account Name: Benjamin M
    Chang Routing Number: 0210-0008-9 Bank Name: Citibank N.A.

    Citibank SWIFT Code: CITIUS33

    Intermediary Bank: 0210-0008-9 (same as SWIFT code) Domicile address is:
    52 E. 14th St New York, NY 10003

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]